<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
<front>
<journal-meta><journal-id journal-id-type="nlm-ta">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosntds</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Neglected Tropical Diseases</journal-title></journal-title-group><issn pub-type="epub">1935-2735</issn><publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="publisher-id">10-PNTD-RA-1310R2</article-id><article-id pub-id-type="doi">10.1371/journal.pntd.0000850</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Biochemistry/Drug Discovery</subject><subject>Biochemistry/Transcription and Translation</subject><subject>Chemical Biology/Small Molecule Chemistry</subject><subject>Infectious Diseases/Helminth Infections</subject><subject>Infectious Diseases/Neglected Tropical Diseases</subject><subject>Infectious Diseases/Tropical and Travel-Associated Diseases</subject></subj-group></article-categories><title-group><article-title>RNA Interference in <italic>Schistosoma mansoni</italic> Schistosomula: Selectivity, Sensitivity and Operation for Larger-Scale Screening</article-title><alt-title alt-title-type="running-head">RNAi in <italic>S. mansoni</italic> Schistosomula</alt-title></title-group><contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple"><name name-style="western"><surname>Štefanić</surname><given-names>Saša</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="fn" rid="fn1"><sup>¤a</sup></xref></contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple"><name name-style="western"><surname>Dvořák</surname><given-names>Jan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="fn" rid="fn2"><sup>¤b</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Horn</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Braschi</surname><given-names>Simon</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="fn" rid="fn3"><sup>¤c</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sojka</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ruelas</surname><given-names>Debbie S.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="fn" rid="fn4"><sup>¤d</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Suzuki</surname><given-names>Brian</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lim</surname><given-names>Kee-Chong</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hopkins</surname><given-names>Stephanie D.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>McKerrow</surname><given-names>James H.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Caffrey</surname><given-names>Conor R.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group><aff id="aff1"><label>1</label><addr-line>Sandler Center for Drug Discovery, California Institute for Quantitative Biosciences (QB3), University of California San Francisco, San Francisco, California, United States of America</addr-line>       </aff><aff id="aff2"><label>2</label><addr-line>Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Praha, Czech Republic</addr-line>       </aff><aff id="aff3"><label>3</label><addr-line>Institute of Parasitology, Biology Centre, Academy of Sciences of the Czech Republic, České Budějovice, Czech Republic</addr-line>       </aff><contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Jones</surname><given-names>Malcolm K.</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group><aff id="edit1">University of Queensland, Australia</aff><author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">conor.caffrey@ucsf.edu</email></corresp>
<fn fn-type="current-aff" id="fn1"><label>¤a</label><p>Current address: Institute of Parasitology, University of Zurich, Zurich, Switzerland</p></fn>
<fn fn-type="current-aff" id="fn2"><label>¤b</label><p>Current address: Institute of Parasitology, Biology Centre, Academy of Sciences of the Czech Republic, České Budějovice Czech Republic</p></fn>
<fn fn-type="current-aff" id="fn3"><label>¤c</label><p>Current address: Abcam Plc, Cambridge, United Kingdom</p></fn>
<fn fn-type="current-aff" id="fn4"><label>¤d</label><p>Current address: Gladstone Institute of Virology and Immunology, San Francisco, California, United States of America</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: SŠ JD MH SB DS CRC. Performed the experiments: SŠ JD MH SB DS DSR BS K-CL SDH CRC. Analyzed the data: SŠ JD MH SB DS DSR BS CRC. Wrote the paper: SŠ JD MH JHM CRC.</p></fn>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn></author-notes><pub-date pub-type="collection"><month>10</month><year>2010</year></pub-date><pub-date pub-type="epub"><day>19</day><month>10</month><year>2010</year></pub-date><volume>4</volume><issue>10</issue><elocation-id>e850</elocation-id><history>
<date date-type="received"><day>25</day><month>6</month><year>2010</year></date>
<date date-type="accepted"><day>16</day><month>9</month><year>2010</year></date>
</history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2010</copyright-year><copyright-holder>Štefanić et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract><sec>
<title>Background</title>
<p>The possible emergence of resistance to the only available drug for schistosomiasis spurs drug discovery that has been recently incentivized by the availability of improved transcriptome and genome sequence information. Transient RNAi has emerged as a straightforward and important technique to interrogate that information through decreased or loss of gene function and identify potential drug targets. To date, RNAi studies in schistosome stages infecting humans have focused on single (or up to 3) genes of interest. Therefore, in the context of standardizing larger RNAi screens, data are limited on the extent of possible off-targeting effects, gene-to-gene variability in RNAi efficiency and the operational capabilities and limits of RNAi.</p>
</sec><sec>
<title>Methodology/Principal Findings</title>
<p>We investigated <italic>in vitro</italic> the sensitivity and selectivity of RNAi using double-stranded (ds)RNA (approximately 500 bp) designed to target 11 <italic>Schistosoma mansoni</italic> genes that are expressed in different tissues; the gut, tegument and otherwise. Among the genes investigated were 5 that had been previously predicted to be essential for parasite survival. We employed mechanically transformed schistosomula that are relevant to parasitism in humans, amenable to screen automation and easier to obtain in greater numbers than adult parasites. The operational parameters investigated included defined culture media for optimal parasite maintenance, transfection strategy, time- and dose- dependency of RNAi, and dosing limits. Of 7 defined culture media tested, Basch Medium 169 was optimal for parasite maintenance. RNAi was best achieved by co-incubating parasites and dsRNA (standardized to 30 µg/ml for 6 days); electroporation provided no added benefit. RNAi, including interference of more than one transcript, was selective to the gene target(s) within the pools of transcripts representative of each tissue. Concentrations of dsRNA above 90 µg/ml were directly toxic. RNAi efficiency was transcript-dependent (from 40 to &gt;75% knockdown relative to controls) and this may have contributed to the lack of obvious phenotypes observed, even after prolonged incubations of 3 weeks. Within minutes of their mechanical preparation from cercariae, schistosomula accumulated fluorescent macromolecules in the gut indicating that the gut is an important route through which RNAi is expedited in the developing parasite.</p>
</sec><sec>
<title>Conclusions</title>
<p>Transient RNAi operates gene-selectively in <italic>S. mansoni</italic> newly transformed schistosomula yet the sensitivity of individual gene targets varies. These findings and the operational parameters defined will facilitate larger RNAi screens.</p>
</sec></abstract><abstract abstract-type="summary"><title>Author Summary</title>
<p>RNA interference (RNAi) is a technique to selectively suppress mRNA of individual genes and, consequently, their cognate proteins. RNAi using double-stranded (ds) RNA has been used to interrogate the function of mainly single genes in the flatworm, <italic>Schistosoma mansoni</italic>, one of a number of schistosome species causing schistosomiasis. In consideration of large-scale screens to identify candidate drug targets, we examined the selectivity and sensitivity (the degree of suppression) of RNAi for 11 genes produced in different tissues of the parasite: the gut, tegument (surface) and otherwise. We used the schistosomulum stage prepared from infective cercariae larvae which are accessible in large numbers and adaptable to automated screening platforms. We found that RNAi suppresses transcripts selectively, however, the sensitivity of suppression varies (40%–&gt;75%). No obvious changes in the parasite occurred post-RNAi, including after targeting the mRNA of genes that had been computationally predicted to be essential for survival. Additionally, we defined operational parameters to facilitate large-scale RNAi, including choice of culture medium, transfection strategy to deliver dsRNA, dose- and time-dependency, and dosing limits. Finally, using fluorescent probes, we show that the developing gut allows rapid entrance of dsRNA into the parasite to initiate RNAi.</p>
</abstract><funding-group><funding-statement>The research was supported by the Sandler Foundation and, in part, by a Collaborative Research Project grant to CRC (WHO T24/181/101, ID # A50567) from the United Nations Children's Fund/United Nations Development Programme/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases (TDR). JD was supported by a FP7Marie Curie - International Re-integration Grant (248642) and by a Czech Ministry of Education, Youth and Sports (MÅ MT) grant (ME1001) awarded under the auspices of the American Science Information Center (AMVIS). SS was supported by a Prospective Scientists Fellowship (PBZHA-121000) from the Swiss National Science Foundation. MH was supported by a grant (203/09/1585) from the Grant Agency of the Czech Republic (GACR), a research project grant Z40550506 and by the Academy of Science of the Czech Republic. DS was supported by a Visiting Scholar Fulbright award (2008-21-06), a grant from the GACR (KJB600960911) and by the Research Center No. LC06009 from the MÅ MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="16"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Schistosomiasis is one of a number of ‘neglected tropical diseases’ (NTDs) associated with extreme poverty in the world's ‘bottom billion’ people <xref ref-type="bibr" rid="pntd.0000850-Hotez1">[1]</xref>. Caused by a parasitic flatworm, the disease can be fatal, but is better known for its chronicity of infection (e.g., <xref ref-type="bibr" rid="pntd.0000850-Vieira1">[2]</xref>). Clinical manifestations of chronic infection include malaise, anemia and wasting, and poor cognitive performance in children <xref ref-type="bibr" rid="pntd.0000850-Bell1">[3]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Gryseels1">[4]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Hotez2">[5]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Jukes1">[6]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Wu1">[7]</xref>. Infection with <italic>Schistosoma haematobium</italic> is associated with an increased risk of bladder cancer <xref ref-type="bibr" rid="pntd.0000850-Badawi1">[8]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Rollinson1">[9]</xref> and due to the compromised integrity of the lower female genital tract, with HIV infection <xref ref-type="bibr" rid="pntd.0000850-Hotez1">[1]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Rollinson1">[9]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Kjetland1">[10]</xref>.</p>
<p>Because treatment and control of schistosomiasis has come to rely on a single drug, praziquantel (PZQ; <xref ref-type="bibr" rid="pntd.0000850-Caffrey1">[11]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Cioli1">[12]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Doenhoff1">[13]</xref>), concern remains over the possible emergence and establishment of clinically relevant drug resistance <xref ref-type="bibr" rid="pntd.0000850-Doenhoff2">[14]</xref>. There are reports of decreased, if sometimes, transient <xref ref-type="bibr" rid="pntd.0000850-Botros1">[15]</xref>, susceptibility by field-isolates of parasite to PZQ <xref ref-type="bibr" rid="pntd.0000850-Melman1">[16]</xref>. The risk of resistance to PZQ <xref ref-type="bibr" rid="pntd.0000850-Doenhoff2">[14]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Smits1">[17]</xref> is all the more relevant given the impetus to increase access to this and other anthelmintics via integrated mass administration programs <xref ref-type="bibr" rid="pntd.0000850-Brady1">[18]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Hotez3">[19]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Lammie1">[20]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Molyneux1">[21]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Utzinger1">[22]</xref>. Thus, it remains a priority to identify and develop alternative chemo- and immuno-therapeutic interventions for schistosomiasis, and progress is being made in both these areas <xref ref-type="bibr" rid="pntd.0000850-AbdulGhani1">[23]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Abdulla1">[24]</xref>, <xref ref-type="bibr" rid="pntd.0000850-CorraSoares1">[25]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Keiser1">[26]</xref>, <xref ref-type="bibr" rid="pntd.0000850-McManus1">[27]</xref>.</p>
<p>Key initial tasks for drug development are the identification and validation of gene products for which modulation by chemical and/or genetic means translates to impaired cell/organism survival. For schistosomes, comprehensive transcriptome <xref ref-type="bibr" rid="pntd.0000850-Fitzpatrick1">[28]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Gobert1">[29]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Jolly1">[30]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Liu1">[31]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Oliveira1">[32]</xref>, <xref ref-type="bibr" rid="pntd.0000850-VerjovskiAlmeida1">[33]</xref>, <xref ref-type="bibr" rid="pntd.0000850-VerjovskiAlmeida2">[34]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Williams1">[35]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Hu1">[36]</xref> and genome sequence information <xref ref-type="bibr" rid="pntd.0000850-Berriman1">[37]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Liu2">[38]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Tsai1">[39]</xref> is now accessible through interrogable databases <xref ref-type="bibr" rid="pntd.0000850-Berriman1">[37]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Liu3">[40]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Zerlotini1">[41]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Agero1">[42]</xref>. These databases have facilitated new strategies, e.g., <xref ref-type="bibr" rid="pntd.0000850-Beckstette1">[43]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Margulies1">[44]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Ptacek1">[45]</xref>, with which potential gene targets have been identified, e.g., <xref ref-type="bibr" rid="pntd.0000850-Caffrey2">[46]</xref>. Coincident with these developments is the continued focus to improve a number of reverse genetic tools to define gene function <xref ref-type="bibr" rid="pntd.0000850-Brindley1">[47]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Dvok1">[48]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Grevelding1">[49]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Mann1">[50]</xref>. Since the first reports in 2003 <xref ref-type="bibr" rid="pntd.0000850-Boyle1">[51]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Skelly1">[52]</xref>, transient RNA interference (RNAi) with either long or short-interfering (si) double-stranded (ds)RNA has proven a straightforward and important tool to study loss of or decreased function for selected genes of interest, including proteases <xref ref-type="bibr" rid="pntd.0000850-Correnti1">[53]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Delcroix1">[54]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Morales1">[55]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Rinaldi1">[56]</xref>,kinases <xref ref-type="bibr" rid="pntd.0000850-Swierczewski1">[57]</xref>, TGF-beta receptor <xref ref-type="bibr" rid="pntd.0000850-Osman1">[58]</xref>, aquaporin <xref ref-type="bibr" rid="pntd.0000850-Faghiri1">[59]</xref>, glucose transporters <xref ref-type="bibr" rid="pntd.0000850-KrautzPeterson1">[60]</xref>, tetraspanins <xref ref-type="bibr" rid="pntd.0000850-Tran1">[61]</xref> and redox-associated enzymes <xref ref-type="bibr" rid="pntd.0000850-Kumagai1">[62]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Kuntz1">[63]</xref>. In some of these studies obvious phenotypes that affected parasite vitality and/or survival were obtained. This evidence for RNAi in schistosomes is underpinned by <italic>in silico</italic> and experimental data to suggest that the necessary RNAi molecular machinery is present <xref ref-type="bibr" rid="pntd.0000850-VerjovskiAlmeida1">[33]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Gomes1">[64]</xref>, <xref ref-type="bibr" rid="pntd.0000850-KrautzPeterson2">[65]</xref>, <xref ref-type="bibr" rid="pntd.0000850-KrautzPeterson3">[66]</xref>. Accordingly, larger scale RNAi screening campaigns of schistosomes can be now envisaged.</p>
<p>To date, RNAi studies with schistosomes relevant to infection in humans have focused on single (or up to 3; <xref ref-type="bibr" rid="pntd.0000850-Morales1">[55]</xref>, <xref ref-type="bibr" rid="pntd.0000850-KrautzPeterson2">[65]</xref>) genes of interest using different developmental stages and experimental conditions. Thus, the studies only partially contribute to standardizing a set of conditions that are applicable to larger scale investigations of gene function. Furthermore, the degree to which complicating factors such as individual gene susceptibility to RNAi and ‘off-targeting’ (whereby dsRNA can direct the RNAi machinery to target transcripts other than that intended) occur is unknown. The latter phenomenon can confound interpretations of loss-of-function <xref ref-type="bibr" rid="pntd.0000850-Hannon1">[67]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Jackson1">[68]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Kulkarni1">[69]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Ma1">[70]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Sarov1">[71]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Sudbery1">[72]</xref>, especially when phenotypes are generated <xref ref-type="bibr" rid="pntd.0000850-Fedorov1">[73]</xref>. Both issues were highlighted in a recent RNAi phenotypic screen of 32 genes in the mother sporocyst stage of <italic>Schistosoma mansoni</italic> that parasitizes the snail vector <xref ref-type="bibr" rid="pntd.0000850-deMoraesMouro1">[74]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Mouro1">[75]</xref>.</p>
<p>As a pre-requisite to larger RNAi-based screens of schistosome stages infecting humans, we investigated the issues of target selectivity and sensitivity of RNAi for 11 gene transcripts expressed in different tissues of <italic>S. mansoni</italic>, including genes predicted <italic>in silico</italic> as being essential to parasite survival <xref ref-type="bibr" rid="pntd.0000850-Caffrey2">[46]</xref>. We focused on mechanically transformed schistosomula, which, compared to adult schistosomes, are easier to procure in their hundreds of thousands from snails and adaptable to automated higher throughput screening technologies <xref ref-type="bibr" rid="pntd.0000850-Abdulla2">[76]</xref>. Schistosomula also offer the opportunity to identify genes of potential value as chemo- or immuno-therapeutic targets prior to the onset of disease pathology and morbidity associated with egg-laying adults. At the same time, we examined a number of operational parameters (optimal medium for parasite maintenance, transfection strategy and time-, and dose-dependencies of RNAi) for which refinement would better facilitate larger-scale loss-of-function screens.</p>
</sec><sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2a">
<title>Ethics Statement</title>
<p>Maintenance of and experiments with vertebrate animals were carried out in accordance with protocols approved by the Institutional Animal Care and Use Committee (IACUC) at UCSF.</p>
</sec><sec id="s2b">
<title><italic>S. mansoni</italic> life-cycle and preparation of schistosomula</title>
<p>A Puerto Rican isolate of <italic>S. mansoni</italic> is maintained in the laboratory using the intermediate snail host, <italic>Biomphalaria glabrata</italic> and the Golden Syrian hamster, <italic>Mesocricetus auratus</italic>, (infected at 5–6 weeks old; Simonsen) as the definitive host <xref ref-type="bibr" rid="pntd.0000850-Abdulla2">[76]</xref>. Methods for the preparation of newly transformed schistosomula (hereafter termed schistosomula) are described previously <xref ref-type="bibr" rid="pntd.0000850-Abdulla2">[76]</xref>. Essentially, the procedure involves cleaning cercariae from snail water and mechanically shearing cercarial tails from heads <xref ref-type="bibr" rid="pntd.0000850-Colley1">[77]</xref> (the nascent schistosomula) in ice-chilled Basch Incomplete Medium 169 <xref ref-type="bibr" rid="pntd.0000850-Basch1">[78]</xref> (custom synthesized at the UCSF Cell Culture Facility; containing 100 U/ml penicillin and 100 µg/ml streptomycin, but without FBS). Schistosomula are collected and washed three times in the same medium and kept on ice for a maximum of 1 h prior to dsRNA treatment.</p>
</sec><sec id="s2c">
<title>Media evaluation test</title>
<p>To compare the effects of different defined culture media on parasite vitality, 200–300 schistosomula were incubated in 96-well flat-bottom plates (Corning) containing 200 µL medium, 5% FBS and 100 U/ml penicillin and 100 µg/ml streptomycin for up to 7 days at 5% CO<sub>2</sub> and 37°C. Media tested were: Basch Medium 169; DMEM (high glucose; UCSF cell culture facility code CCFAA005); F-12 (CCFAB002); Liebovitz's L-15 Medium without NaHCO<sub>3</sub> (CCFDY003); M199 with Earle's Salts (CCFAX001); RPMI 1640 (containing 2mM glutamine (CCFAE001) and supplemented with 10 mM HEPES), and Schneider's Drosophila Medium (INVZR512). Phenotypic alterations in translucency, shape and motility <xref ref-type="bibr" rid="pntd.0000850-Abdulla2">[76]</xref> were assessed every second day. Still and time-lapse image recordings were made on the seventh day.</p>
</sec><sec id="s2d">
<title>Transcript targets</title>
<p>We selected 11 genes encoding diverse proteins and putatively expressed in different tissues (gut, tegument and otherwise) in order to assess any variability in the ability to suppress gene transcription. For gut genes, we chose 3 well-characterized <italic>S. mansoni</italic> proteases; cathepsin B1 (using a dsRNA targeting both isoforms - CB1.1 (AJ506157) and CB1.2, (AJ506158), cathepsin C (CC, Z32531) and cathepsin D (CD, U60995) <xref ref-type="bibr" rid="pntd.0000850-Delcroix1">[54]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Caffrey3">[79]</xref>. For the tegument, 3 genes were chosen; CB2 (AJ312106), annexin (XP_002578945.1) and Sm29 (XP_002578407.1). The respective proteins have been bio/immuno-chemically localized to the parasite surface <xref ref-type="bibr" rid="pntd.0000850-Braschi1">[80]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Tararam1">[81]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Caffrey4">[82]</xref> although CB2 is also localized in the parenchyma <xref ref-type="bibr" rid="pntd.0000850-Caffrey4">[82]</xref>. Annexin is also a protein common to most eukaryote plasma membranes <xref ref-type="bibr" rid="pntd.0000850-Rescher1">[83]</xref> and may, therefore, be more generally distributed in the parasite. The remaining 5 targets are considered to be more generally distributed and have been predicted to be essential in <italic>S. mansoni</italic> in a recent comparative genomics analysis <xref ref-type="bibr" rid="pntd.0000850-Caffrey2">[46]</xref>: glycogen synthase kinase-3 (GSK3; XP_002572305.1), methionine aminopeptidase (MetAP; XP_002572573.1), protein phosphatase-2a (PP-2a; XP_002574514.1), neuroendocrine convertase (NEC; XP_002569775.1) and n-myristoyl transferase (nMT; XP_002571399.1). <xref ref-type="supplementary-material" rid="pntd.0000850.s002">Table S1</xref> describes the primers used for dsRNA synthesis (the T7 DNA polymerase binding motif is shown in bold characters) and the quantitative real-time (qRT)-PCR primers used to measure RNAi. For dsRNA design, the nucleotide sequence encoding the open reading frame of each gene target was examined using the nucleotide BLAST service at NCBI (constrained to the <italic>Schistosoma</italic> taxid ID of 6181). Sequence areas displaying homology (especially for identical stretches of 10 nucleotides or more) with other <italic>Schistosoma</italic> genes were avoided in order to decrease the risk of off-targeting.</p>
</sec><sec id="s2e">
<title>Synthesis of dsRNA and Cy5-labeled dsRNA</title>
<p>PCR products of approximately 500 bp in size were amplified from cDNA prepared from 6 day-old <italic>in vitro</italic> cultivated <italic>S. mansoni</italic> schistosomula cDNA using gene-specific primers for the targeted genes (<xref ref-type="supplementary-material" rid="pntd.0000850.s002">Table S1</xref>). The expected size of the amplicon was measured by electrophoresis in 1% agarose gels and identity confirmed by DNA sequencing. Amplicons were then used as templates for two more PCR reactions using either a sense or antisense primer containing a 5′-positioned T7 polymerase promoter sequence. After gel purification, each of the two PCR products was separately reverse transcribed <italic>in vitro</italic> using the T7 RiboMAX express RNAi system (Promega) and the resulting single-stranded RNA pooled to generate dsRNA that was then treated with RNase A and DNase. The manufacturer's instructions were applied apart from scaling the reverse transcription reaction to 100 µl and allowing it to proceed overnight at 37°C with a final hour at 42°C. The dsRNA was precipitated using 1 volume of 10% 3 M sodium acetate (pH 5.2) in 100% isopropanol, and pelleted at 12 000 <italic>g</italic> for 15 min at 4°C. The pellet was washed in 70% ethanol, air-dried and resuspended in water. The concentration of dsRNA was measured in an ND-1000 Spectrophotometer (Nanodrop Technologies) and adjusted to 3.0 mg/ml. The size and integrity of the resulting dsRNA was confirmed by electrophoresis in 1% agarose gels and stored at −80°C until use.</p>
<p>For synthesis of Cy5-labeled dsRNA to CC, CB1 and the <italic>Discosoma</italic> sp. fluorescent protein, mCherry (<xref ref-type="bibr" rid="pntd.0000850-Shaner1">[84]</xref>; GenBank AY678264), an aliquot of dsRNA (40 µg) was labeled using the <italic>Label</italic> IT Nucleic Acid Labeling Reagent (Mirus) according to the manufacturer's instructions. Labeling efficiency was monitored using an ND-1000 Spectrophotometer.</p>
</sec><sec id="s2f">
<title>Treatment of schistosomula with dsRNA</title>
<p>Schistosomula were divided into groups of approximately 400 and incubated in 24-well plates containing 1 ml Complete Medium 169 (plus 5% FBS) and dsRNA (30 µg unless otherwise stated) targeting either schistosome transcripts or mCherry that was employed as a schistosome-unspecific control. Incubations were continued for 6 days at 37°C and 5% CO<sub>2</sub>. To isolate for the effect of electroporation on RNAi efficiency, the following additional incubations were set up. Groups of 400 schistosomula were transferred to 4 mm electroporation cuvets (Bio-Rad Laboratories) in Basch Incomplete Medium 169. DsRNA (30 µg) was then added (usually as a 10 µL aliquot) in Incomplete Medium 169 to give a final volume of 100 µl. Electroporation was carried at 125 V for 20 ms <xref ref-type="bibr" rid="pntd.0000850-Correnti1">[53]</xref> using a Bio-Rad GenePulser Xcell. Worms were then suspended in 1 ml Complete Medium 169 and incubations continued for 6 days. A second group of worms was electroporated as above, but following electroporation, worms were washed 10 times in Incomplete Medium 169 to remove as much dsRNA as possible and then incubated at 37°C. A third group was electroporated in the absence of dsRNA, and immediately thereafter dsRNA was added for incubation at 37°C.</p>
</sec><sec id="s2g">
<title>RNA isolation from schistosomula after dsRNA treatment and conversion to cDNA</title>
<p>After 6 days of cultivation, schistosomula were collected, washed 3 times in 1.5 ml PBS and resuspended in 50 µl of Trizol reagent (Invitrogen). Samples were flash frozen in liquid nitrogen and stored at −80°C. During thawing, samples were homogenized with Kontes disposable pellet pestles and microtubes (VWR). Sample volumes were adjusted to 500 µl with Trizol reagent and the temperature adjusted to 65°C for 5 min to improve tissue lysis. To separate nucleoprotein complexes, samples were further incubated at room temperature for 15–20 minutes. Steps to continue the isolation of total RNA with Trizol were performed up until phase separation in chloroform. At this point, the aqueous phase was transferred to a new 1.5 ml microfuge tube containing an equal volume of 75% ethanol. RNA was further purified using the RNeasy Mini Kit (Qiagen) according to the supplied instructions. The concentration of RNA was determined using an ND-1000 Spectrophotometer. Single-stranded cDNA was synthesized from total RNA using SuperScript III reverse transcriptase (Invitrogen) and an oligo d(T)<sub>18</sub> reverse primer according to the manufacturer's protocol. The resulting cDNA was purified using a DNA Clean &amp; Concentrator-5 (Zymo Research Corporation) and stored in water at −80°C.</p>
</sec><sec id="s2h">
<title>Primer design and optimization, and qRT-PCR analyses</title>
<p>Primers were designed using the Primer 3 software (<ext-link ext-link-type="uri" xlink:href="http://frodo.wi.mit.edu/" xlink:type="simple">http://frodo.wi.mit.edu/</ext-link>, <xref ref-type="bibr" rid="pntd.0000850-Rozen1">[85]</xref>) employing a target product size of 150–200 bp and a primer melting temperature of 55°C. Primer design excluded outputs containing stretches of four or more of identical nucleotides that might interfere with binding specificity. Primers were designed to bind outside of the region targeted by the dsRNA to avoid the possibility of amplifying carryover PCR product used as a template in dsRNA synthesis reaction. The specificity of each primer sequence was confirmed by BLAST analysis. Primers were purchased from Integrated DNA Technologies at the 25 nM scale and without additional purification procedures. The size of PCR amplicon generated by each primer pair was visually inspected by 1% agarose gel electrophoresis to ensure that the intended sized product was in fact amplified. The amplification efficiency of each qRT-PCR primer set was evaluated in triplicate over at least three and five dilutions of primers and cDNA template, respectively. The cycle threshold (C<sub>T</sub>) values arising were plotted as a function of the dilution of cDNA <xref ref-type="bibr" rid="pntd.0000850-Nolan1">[86]</xref>. Optimal efficiencies generated curves with slopes of between −3.5 and −3.2 (100% efficiency is represented by a gradient of −3.32). R<sup>2</sup> coefficients of ≥0.98 indicated high reproducibility for the triplicate reactions. Primer sets were also checked for their dissociation (melting) curves using the appropriate setting of the MxPro QPCR software package (see below). Only those primers displaying optimal efficiencies and generating single dissociation peaks (the latter demonstrative of a specific reaction without, for example, primer dimerization) <xref ref-type="bibr" rid="pntd.0000850-Bookout1">[87]</xref> were considered further. Our experience has been that, for each transcript target, two to four primer sets needed to be tested in order to identify an optimal pair.</p>
<p>Quantitative RT-PCR was carried out in an MX 3005P Real-Time PCR cycler (Stratagene, Agilent Technologies, Inc.) using the LightCycler 480 SYBR Green I Master mix (Roche Diagnostics). <italic>S. mansoni</italic> cytochrome C oxidase I (GenBank AF216698, <xref ref-type="bibr" rid="pntd.0000850-Le1">[88]</xref>) served as the sample normalizing gene transcript <xref ref-type="bibr" rid="pntd.0000850-Dvok2">[89]</xref>. This transcript is highly and constitutively expressed in a number of <italic>S. mansoni</italic> life-cycle stages <xref ref-type="bibr" rid="pntd.0000850-Jolly1">[30]</xref>. Controls for genomic DNA contamination (minus reverse transcriptase) and reagent purity (water control) were included for each sample. Reactions were carried out in a final volume of 25 µl in 96 well plates (Stratagene). The amplification profile consisted of an initial hot start (95°C for 10 min), followed by 40 cycles comprising 95°C for 30 s, 55°C for 60 s and 72°C for 60 s, and ended with a single cycle of 95°C for 60 s, 55°C for 30 s and 95°C for 30 s. PCR reactions were performed in duplicate for each cDNA sample. Also, at least one additional biological replicate, i.e., with cDNA arising from a separate dsRNA application, was performed. To ensure precision, the entire qPCR experiment was repeated when C<sub>T</sub> values of duplicate reactions differed by 0.5 or more (indicative of pipeting error). Using the MxPro QPCR Software version 4.01 (Stratagene), the 2<sup>−ΔΔC</sup><sub>T</sub> method <xref ref-type="bibr" rid="pntd.0000850-Livak1">[90]</xref> was applied to measure transcript levels following dsRNA treatment. Transcript levels were expressed as a percentage of those following exposure to schistosome-unspecific mCherry dsRNA.</p>
</sec><sec id="s2i">
<title>Irreversible active site labeling of SmCC</title>
<p>To verify RNAi of SmCC at the protein level, the fluorescent and selective cathepsin C affinity probe bodipy-labeled FY01 <xref ref-type="bibr" rid="pntd.0000850-Yuan1">[91]</xref> was incubated with protein extract from schistosomula exposed to SmCC-dsRNA. Extracts from worms incubated with mCherry-dsRNA served as a control. Soluble protein extracts were prepared by sonication in 50 mM citrate, 100 mM phosphate, pH 5.0 over an ice bath. After centrifugation at 8 000 <italic>g</italic> and 4°C for 5 min, supernatants were collected. An aliquot (2 µg protein) was incubated for 1 h at 37°C with 1 µM bodipy-labeled FY01 in 50 mM sodium acetate pH 5.5 containing 2.5 mM DTT, 1 mM EDTA and 1 µM each of the respective aspartic and cathepsin B (cysteine protease) inhibitors, pepstatin A and CA-074 (N-[L-3-trans-propylcarbamoyloxirane- 2-carbonyl]-Ile-Pro-OH <xref ref-type="bibr" rid="pntd.0000850-Murata1">[92]</xref>; Bachem). The labeling reaction was stopped by heating to 70°C for 15 min in reducing Laemmli sample buffer. The reaction mixture was resolved by SDS-PAGE through 15% polyacrylamide gels and visualized in a Typhoon 8600 Imager (GE Healthcare) using excitation at 532 nm (green laser) and a 580 nm (BP30 nm) emission filter.</p>
<p>SmCC activity was also detected by hydrolysis of the cathepsin C fluorogenic substrate, Gly-Arg-AMC, as described previously <xref ref-type="bibr" rid="pntd.0000850-Sojka1">[93]</xref>, in the presence and absence of 10 µM of the following protease inhibitors (Bachem): the general Clan CA cysteine protease inhibitor, K11777 (N-methyl-piperazine-Phe-homoPhe-vinyl sulfone phenyl <xref ref-type="bibr" rid="pntd.0000850-Brmme1">[94]</xref>); the cathepsin B-selective inhibitor, CA-074; and the cathepsin L-preferential inhibitor, Z-Phe-Phe-DMK (benzyloxy carbonyl-Phe-Phe-diazomethane <xref ref-type="bibr" rid="pntd.0000850-Kirschke1">[95]</xref>). Assays were performed in triplicate.</p>
</sec><sec id="s2j">
<title>Preparation of recombinant mCherry fluorescent protein</title>
<p>The mushroom anemone (<italic>Discosoma</italic> sp.) red fluorescent protein, mCherry <xref ref-type="bibr" rid="pntd.0000850-Shaner1">[84]</xref>, was recombinantly expressed in TOP10 chemically competent <italic>E. coli</italic> (Invitrogen). Bacteria that had been transformed with the mCherry open reading frame as part of a pUC18 plasmid backbone were grown overnight at 37°C in 500 ml LB medium containing 100 µg/ml of ampicillin and 20 mM glucose. After centrifugation at 3 000 <italic>g</italic> for 10 min, bacteria were incubated for 4 h in fresh LB medium containing 1 mM IPTG (isopropyl-β-D-thio-galactoside) and harvested by centrifugation for 10 min at 4 000 <italic>g</italic>. The pellet was re-suspended in 50 ml 100 mM phosphate buffer, pH 8.0, and sonicated using a Branson Sonifier 250 adjusted to a 60% duty cycle and an output control of 6. The material was centrifuged at 10 000 <italic>g</italic> for 15 min and the supernatant, containing recombinant mCherry, was collected. Heat denaturation in a water bath at 80°C for 40 min followed by centrifugation at 10 000 <italic>g</italic> for 15 min was employed to separate bacterial proteins from the heat-stable mCherry protein in the supernatant. The supernatant was decanted and concentrated over an Amicon Ultra-50 10K (Millipore) filter to a final volume of 5 ml. The sample was size fractionated over a Superdex 200 column (GE- Healthcare) pre-equilibrated with 100 mM phosphate buffer, pH 8.0. Eluted fractions containing visible red mCherry protein (4 mg/ml) were pooled and stored at −20°C.</p>
</sec><sec id="s2k">
<title>Uptake of exogenous material by schistosomula <italic>in vitro</italic></title>
<p>Schistosomula were co-incubated in 1 ml Complete Medium 169 with either 30 µg Cy5-labeled SmCB1- or mCherry- dsRNA, 200 µg recombinant mCherry protein or 2 µL washed and packed human erythrocytes. Uptake was monitored as a function of time, usually every half hour out to 4 h, at 20 h and thereafter, every day out to 4 days. For Cy5-labeled dsRNA, worms were washed 4 times in Incomplete Medium 169 before imaging with a laser scanning microscope (LSM 510 META; Carl Zeiss MicroImaging, Inc.). For mCherry protein, fluorescence was visualized without washing using an Axiovert 40CFL inverted microscope. Bright field images of parasites in the presence of erythrocytes were acquired using an Axiovert 40C inverted microscope.</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Of seven defined culture media tested, Basch Medium 169 optimally maintains schistosomula</title>
<p>Prior to RNAi experiments with newly transformed schistosomula, we wished to evaluate the effects of different defined culture media (containing 100 U/ml penicillin and 100 µg/ml streptomycin and 5% FBS) on parasite vitality and viability. These effects were visually determined as phenotypic alterations in parasite motility, shape and translucence <xref ref-type="bibr" rid="pntd.0000850-Abdulla2">[76]</xref>. Time-lapse image recordings, taken at day 7 of the incubation, are provided as <xref ref-type="supplementary-material" rid="pntd.0000850.s003">Videos S1</xref>, <xref ref-type="supplementary-material" rid="pntd.0000850.s004">S2</xref>, <xref ref-type="supplementary-material" rid="pntd.0000850.s005">S3</xref>, <xref ref-type="supplementary-material" rid="pntd.0000850.s006">S4</xref>, <xref ref-type="supplementary-material" rid="pntd.0000850.s007">S5</xref>, <xref ref-type="supplementary-material" rid="pntd.0000850.s008">S6</xref>, <xref ref-type="supplementary-material" rid="pntd.0000850.s009">S7</xref> and provide the best visual medium to compare and contrast the worm responses to the incubation conditions. Still images from these experiments are also presented in <xref ref-type="fig" rid="pntd-0000850-g001">Figure 1</xref>. By the seventh day of incubation, relative to Basch medium 169, DMEM (high glucose), F-12, Liebowitz and M199 media had generated varying degrees of deformed, rounded and/or darkened parasites, often accompanied by slowed and less dynamic motility. In RPMI and Schneider's media, additional and more severe effects (degenerating parasites and widespread death) were noted, which appeared as early as day 2 of the incubation and progressed to approximately &gt;80% parasite mortality by day 7. For RPMI, this was also case when the medium was exchanged every 2 days. In contrast, in Basch medium 169, parasites were more uniform in translucency, shape and motility with less than 10% mortality at day 7. Based on these results, therefore, we employed Basch medium 169 for all further experiments.</p>
<fig id="pntd-0000850-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0000850.g001</object-id><label>Figure 1</label><caption>
<title>Manifestation of phenotypes in newly transformed <italic>S. mansoni</italic> schistosomula by various defined culture media.</title>
<p>Over the course of one week's incubation, parasites in Basch Medium 169 <xref ref-type="bibr" rid="pntd.0000850-Basch1">[78]</xref> appear robust and uniform in shape and appearance. In contrast, DMEM (high glucose), F-12, Liebowitz and M199 media generated different degrees of distorted parasites including rounding and darkening that was often accompanied by slowed and less dynamic motility. For RPMI and Schneider's medium, parasite rounding, degeneration and death were noted by day 2 of the incubation with &gt;80% parasite mortality by day 7. Images were captured using a Zeiss Axiovert 40 C inverted microscope (10× objective) and a Zeiss AxioCam MRc digital camera controlled by AxioVision 40 version 4.5.0.0 software. These images are best viewed in conjunction with <xref ref-type="supplementary-material" rid="pntd.0000850.s003">Videos S1</xref> through <xref ref-type="supplementary-material" rid="pntd.0000850.s009">S7</xref> (taken at the same magnification) to include the effects of media on parasite motility. A second experiment with the same media yielded similar results. Scale bars represent 100 µm.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000850.g001" xlink:type="simple"/></fig></sec><sec id="s3b">
<title>The issue of carry-over contaminating DNA in accurately measuring RNAi</title>
<p>In spite of the mandatory DNase treatment used to remove PCR-derived DNA from dsRNA preparations, the possibility existed that residual DNA would nevertheless serve as template for qPCR should the qPCR primers be designed to amplify within the sequence used to synthesize dsRNA <xref ref-type="bibr" rid="pntd.0000850-Morales1">[55]</xref>, <xref ref-type="bibr" rid="pntd.0000850-deMoraesMouro1">[74]</xref>. This would result in an apparent lack of, or less efficient, transcript knockdown. That this is a legitimate concern (and even with best practice to purify dsRNA according to the appropriate protocol) is shown in <xref ref-type="supplementary-material" rid="pntd.0000850.s001">Figure S1</xref> using ‘purified’ dsRNA to the tegument-associated SmCB2 transcript as an example. A concentration-dependent amplification resulted (<xref ref-type="supplementary-material" rid="pntd.0000850.s001">Figure S1A</xref>) when qPCR primers (Primer set B) were positioned within the sequence employed as template for reverse transcription (<xref ref-type="supplementary-material" rid="pntd.0000850.s001">Figure S1B</xref>). In contrast, primer set A, that targeted an area 5′ of the dsRNA template sequence, produced no such amplification.</p>
</sec><sec id="s3c">
<title>Direct toxicity of dsRNA to schistosomula, and dose- and time-dependency of RNAi</title>
<p>Direct toxicity to schistosomula by dsRNA was evident as greater proportions of parasites that displayed abnormal phenotypes <xref ref-type="bibr" rid="pntd.0000850-Abdulla2">[76]</xref> such as rounding, darkening, slowed motility and outright death, or a combination thereof (<xref ref-type="fig" rid="pntd-0000850-g002">Figure 2</xref>). Using dsRNA to mCherry (or CB1, not shown) and at the highest concentration tested of 210 µg/ml, more than 35% of the parasites appeared abnormal by days 3 and 6 of the incubation (<xref ref-type="fig" rid="pntd-0000850-g002">Figure 2A</xref>). At a concentration of 150 µg/ml, a marked increase in the percentage of distressed parasites was measured between days 3 (12%) and 6 (35%; <xref ref-type="fig" rid="pntd-0000850-g002">Figure 2A and 2B</xref>, lower panel). Concentrations below this (30 and 90 µg/ml) did not increase the percentage of abnormal parasites above the 12% background for the duration of the experiment. Thus, we interpret the data to suggest that the upper concentration limit for dsRNA, without incurring obvious parasite distress, is approximately 90 µg/ml. Operationally, we chose 30 µg/ml dsRNA to provide an increased margin of safety and based on the dsRNA dose-dependency tests for CB1 (<xref ref-type="fig" rid="pntd-0000850-g003">Figure 3A</xref>), MetAP, NEC and PP2a (not shown) indicating that 30 µg/ml was sufficient for maximal RNAi. We chose a period of 6 days for co-incubating dsRNA and parasites as it was sufficient to register maximal transcriptional suppression of CB1, MetAP and PP2a (<xref ref-type="fig" rid="pntd-0000850-g003">Figure 3B, C and D</xref>, respectively).</p>
<fig id="pntd-0000850-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0000850.g002</object-id><label>Figure 2</label><caption>
<title>Direct toxicity by dsRNA to newly transformed schistosomula.</title>
<p>Parasites were incubated in a total volume of 1 ml Basch Complete Medium with various concentrations of dsRNA (aliquots of 70 µl water) to <italic>Discosoma</italic> sp. mCherry <xref ref-type="bibr" rid="pntd.0000850-Shaner1">[84]</xref>. At days 3 and 6, three photographic fields of view per dsRNA concentration were taken and those parasites displaying an obvious loss of shape and morphological integrity counted. The data shown in (A) are the averages of those counts expressed as a percentage of the total number of worms. SD values were less than 10% of the mean. (B) Images of parasites exposed to different concentrations of dsRNA by day 6 of the incubation: arrowheads indicate examples of distressed worms induced by 150 µg/ml dsRNA. Data are representative of two experiments. Similar results were observed with dsRNA to SmCB1. Scale bars represent 100 µm.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000850.g002" xlink:type="simple"/></fig><fig id="pntd-0000850-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0000850.g003</object-id><label>Figure 3</label><caption>
<title>Dose and time dependency of RNAi in newly transformed schistosomula.</title>
<p>Parasites were incubated with (A) varying concentrations of dsRNA or (B, C and D) 30 µg/ml dsRNA for various periods up to 6 days. RNAi was measured by qRT-PCR and data expressed relative to those following parasite exposure to schistosome-unspecific mCherry dsRNA. Asterisks in (A) indicate direct dsRNA toxicity to the parasites (see text and <xref ref-type="fig" rid="pntd-0000850-g002">Figure 2</xref> for details). Each sample was tested in duplicate and representative data from two experiments are shown.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000850.g003" xlink:type="simple"/></fig></sec><sec id="s3d">
<title>RNAi, including more than one transcript target, is selective, however, its efficiency is gene-dependent</title>
<p>Transcripts for the gut-associated proteins CB1, CC and CD are sensitive to RNAi and are robustly suppressed by &gt;75% (<xref ref-type="fig" rid="pntd-0000850-g004">Figure 4A, B and C</xref>, respectively). Importantly, the effect is selective for the intended mRNA within the pool of gut transcripts examined. Attachment of the fluorescent Cy5 label to CB1-(<xref ref-type="fig" rid="pntd-0000850-g004">Figure 4A</xref>) or CC-(not shown) specific dsRNA does not interfere with suppression, or the degree of suppression, of the cognate mRNA. With non-labeled dsRNA targeting CB1, CC and CD, the RNAi effect was long-term, remaining constant out to 3 weeks of incubation without exchanging either culture medium or dsRNA (not shown). For CB1, long-term suppression (&gt;30 days of incubation) of transcript has been previously noted for schistosomula exposed at 3 h <xref ref-type="bibr" rid="pntd.0000850-Correnti1">[53]</xref> and 7 days post-transformation <xref ref-type="bibr" rid="pntd.0000850-KrautzPeterson4">[96]</xref>.</p>
<fig id="pntd-0000850-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0000850.g004</object-id><label>Figure 4</label><caption>
<title>RNAi of gut-associated gene transcripts in newly transformed schistosomula is robust and selective.</title>
<p>Parasites were incubated for 6 days with 30 µg/ml of each of the indicated dsRNA preparations. RNAi was measured by qRT-PCR and data expressed relative to those following parasite exposure to schistosome-unspecific mCherry dsRNA. A negative control (−ve) in which parasites had not been exposed to dsRNA was also included. For each of the targeted genes, (A) SmCB1, (B) SmCC and (C) SmCD, the RNAi effect was selective among the pool of gut-associated transcripts examined. Selective RNAi of SmCB1 was also achieved with 30 µg/ml Cy5-linked dsRNA. Each sample was tested in duplicate and representative data from two experiments are shown.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000850.g004" xlink:type="simple"/></fig>
<p>As exemplified by CB1 and CD (<xref ref-type="fig" rid="pntd-0000850-g005">Figure 5A and B</xref>, respectively), RNAi of more than one transcript at the same time is possible in schistosomula (30 µg/ml dsRNA per transcript target), in this case with &gt;75% suppression. As found for RNAi of single transcripts, the effect is again selective within the pool of transcripts examined. For these experiments, the transcript for cystatin (Cys), a cysteine protease inhibitor (AY334553.1) <xref ref-type="bibr" rid="pntd.0000850-Morales2">[97]</xref>, was included as a non-targeted transcript control.</p>
<fig id="pntd-0000850-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0000850.g005</object-id><label>Figure 5</label><caption>
<title>RNAi of more than one gut-associated gene transcript is robust and selective.</title>
<p>Newly transformed schistosomula were incubated for 6 days with either 30 or 60 µg/ml of the indicated dsRNA preparations depending on whether single or double transcript suppression of SmCB1 (A) or SmCD (B) was being attempted. RNAi was measured by qRT-PCR and data expressed relative to those following parasite exposure to schistosome-unspecific mCherry dsRNA at 60 µg/ml. Included as controls were parasites that had not been exposed to dsRNA (−ve) or that had been co-incubated with dsRNA to the cysteine protease inhibitor cystatin (Cys). Each sample was tested in duplicate and representative data from two experiments are shown.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000850.g005" xlink:type="simple"/></fig>
<p>Confirmation of RNAi at the protein level was sought for CC (<xref ref-type="fig" rid="pntd-0000850-g006">Figure 6</xref>). A 6-day co-incubation of schistosomula and dsRNA targeting CC realized a knockdown of the translation product, measured either as an 80% decrease in the peptidolytic cleavage of the cathepsin C-selective substrate, GR-AMC (<xref ref-type="fig" rid="pntd-0000850-g006">Figure 6A</xref>) or as a loss of the proteolytic signal (at approximately 24 kDa) using the specific active site-directed probe, bodipy-labeled FY01 (<xref ref-type="fig" rid="pntd-0000850-g006">Figure 6B</xref>). Activity in the presence of GR-AMC was not inhibited by the general cysteine protease inhibitor, K11777, or by CA-074 and Z-Phe-Phe-DMK that target cathepsins B and L, respectively. This indicates that only cathepsin C activity was being measured. For CB1, a similar absence of protein was recorded after dsRNA application using immunoblotting with monospecific antibodies (not shown).</p>
<fig id="pntd-0000850-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0000850.g006</object-id><label>Figure 6</label><caption>
<title>RNAi of SmCC is accompanied by decreased translation product measured as proteolytic activity.</title>
<p>(A) Activity in extracts of schistosomula that had been co-incubated for 6 days with 30 µg/ml mCherry (Ch) or SmCC (CC) dsRNA was measured with the cathepsin C-selective peptidyl substrate, GR-AMC. Worm extracts were normalized to 0.4 µg of protein per reaction and the proteolytic activity in extracts from parasites exposed to mCherry dsRNA was set to 100%. (B) Reactivity with the fluorescent cathepsin C-selective activity-based probe (bodipy-labeled FY01; <xref ref-type="bibr" rid="pntd.0000850-Yuan1">[91]</xref>) as assessed by SDS-PAGE. Worm extracts were normalized to 2 µg per labeling reaction. The fluorescent signal at 24 kDa is lost subsequent to exposure to CC-specific dsRNA. Data in (A) are the average of triplicate values (SD values were less the 5% of the mean). Representative data from two experiments are shown.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000850.g006" xlink:type="simple"/></fig>
<p>Robust and selective single and double knockdowns (&gt;75%) were also possible for the tegument transcript targets CB2, annexin and Sm29 using 30 µg/ml dsRNA per transcript (<xref ref-type="fig" rid="pntd-0000850-g007">Figure 7A, B and C</xref>, respectively). This was the case within the pool of tegument transcripts examined and as compared to the gut-associated CB1 employed as a ‘tissue control’.</p>
<fig id="pntd-0000850-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0000850.g007</object-id><label>Figure 7</label><caption>
<title>RNAi of one, or more than one, tegument-associated gene transcript is robust and selective.</title>
<p>Newly transformed schistosomula were incubated for 6 days with either 30 or 60 µg/ml of the indicated dsRNA depending on whether single or double transcript suppression was being attempted. RNAi was measured by qRT-PCR and data expressed relative to those following parasite exposure to schistosome-unspecific mCherry dsRNA at 60 µg/ml. For each of the targeted genes, (A) SmCB2, (B) SmAx (annexin) and (C) Sm29, the RNAi effect was selective among the pool of tegument transcripts examined and also with respect to the transcript for the gut-associated protease, SmCB1, used as a ‘tissue control’. Each sample was tested in duplicate and representative data from two experiments are shown.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000850.g007" xlink:type="simple"/></fig>
<p>For the 5 remaining genes that are considered to be more generally distributed (MetAP, nMT, PP2a, GSK3, and NEC), selective single and double (for MetAP, nMT and PP2a) knockdowns were generated with 30 µg/ml dsRNA per transcript (<xref ref-type="fig" rid="pntd-0000850-g008">Figure 8</xref>). However, compared to the gut and tegument targets, the efficiency of knockdown was more variable. Thus, a decrease of approximately 75% was recorded for MetAP (<xref ref-type="fig" rid="pntd-0000850-g008">Figure 8A</xref>); whereas for nMT and PP2a, decreases of between 40 and 60% were obtained (<xref ref-type="fig" rid="pntd-0000850-g008">Figure 8B and C</xref>). GSK3 and NEC transcripts were more resistant to RNAi with maximum decreases of approximately 40% (<xref ref-type="fig" rid="pntd-0000850-g008">Figure 8D and E</xref>). RNAi of each target did not affect levels of CB1 transcript used as a ‘tissue control’. Likewise, RNAi of CB1 did not affect transcript levels of the other gene targets (<xref ref-type="fig" rid="pntd-0000850-g008">Figure 8F</xref>). Doubling or tripling the concentration to 90 µg/ml dsRNA did not improve RNAi (not shown), nor was it the case that transcript suppression was greater earlier in the 6-day incubation period (as shown when processing samples for transcript levels of MetAP and PP2a at days 2 and 4 of the incubation; <xref ref-type="fig" rid="pntd-0000850-g003">Figure 3C</xref>). Thus, in the present experimental system, the RNAi recorded seems to be the maximal achievable.</p>
<fig id="pntd-0000850-g008" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0000850.g008</object-id><label>Figure 8</label><caption>
<title>For 5 other gene transcripts, RNAi of one, or more than one target is selective, but efficiency varies.</title>
<p>Newly transformed schistosomula were incubated for 6 days with either 30 or 60 µg/ml of the indicated dsRNA depending on whether single or double transcript suppression was being attempted. RNAi was measured by qRT-PCR and data expressed relative to those following parasite exposure to schistosome-unspecific mCherry dsRNA at 60 µg/ml. For each of the targeted genes, (A) SmMetAP, (B) SmnMT (C) SmPP2a, (D) SmGSK3 and (E) SmNEC, the RNAi effect was selective among the pool of genes examined and also with respect to the transcript for the gut-associated protease, SmCB1, used as a ‘tissue control’. Likewise, the corollary experiment (F) indicates that RNAi of CB1 does not affect transcript levels of the other gene targets. Each sample was tested in duplicate and representative data from two experiments are shown.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000850.g008" xlink:type="simple"/></fig>
<p>No striking or obvious phenotypes were observed upon RNAi of any of the 11 gene transcripts over the 6-day incubation period. For the 3 gut-associated and 5 <italic>in silico</italic>-predicted essential genes, this was also the case after 3 week co-incubations and whether or not the culture medium and dsRNA were exchanged weekly (not shown). For CB1 and CD, the same was also true in the presence of washed erythrocytes and was independent of whether single or double RNAi was employed (not shown).</p>
</sec><sec id="s3e">
<title>The contribution by electroporation to RNAi is minor and may depend on the tissue localization of the target</title>
<p>Electroporation has been employed as part of a protocol to deliver nucleic acids to both adult schistosomes and schistosomula e.g., <xref ref-type="bibr" rid="pntd.0000850-Correnti1">[53]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Swierczewski1">[57]</xref>, <xref ref-type="bibr" rid="pntd.0000850-KrautzPeterson4">[96]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Ndegwa1">[98]</xref>. Our experience with electroporation has entailed some risk of contamination of parasite culture consequent on the extra handling required to perform this technique. These issues are of logistical importance when streamlining larger scale RNAi experiments. We, therefore, devised a series of experimental conditions for selected gene targets to determine the contribution to RNAi by electroporation as compared to simple co-incubation.</p>
<p>Co-incubation of dsRNA with schistosomula or electroporation in the presence or absence of dsRNA followed by co-incubation of dsRNA with parasites led to robust transcript suppression (&gt;75%) for each the tissue-representative targets examined, namely CB1 (gut), CB2 (tegument) and MetAP (otherwise; <xref ref-type="fig" rid="pntd-0000850-g009">Figure 9</xref>). In contrast, when worms that had been electroporated in the presence of dsRNA were then immediately washed 10 times prior to incubation in the absence of dsRNA, the RNAi effect was more limited. Thus, for the gut proteases CB1 (<xref ref-type="fig" rid="pntd-0000850-g009">Figure 9A</xref>), CC and CD (not shown), transcript levels were decreased by between 0 and 15% relative to mCherry. Similarly, only an approximate 20% decrease in message was recorded for MetAP when the contribution of electroporation to RNAi was isolated (<xref ref-type="fig" rid="pntd-0000850-g009">Figure 9C</xref>). However, for the tegument targets, CB2 (<xref ref-type="fig" rid="pntd-0000850-g009">Figure 9B</xref>), annexin and Sm29 (not shown), electroporation alone generated a more apparent RNAi of approximately 50%. This suggests that tegument targets may be more amenable to electroporation, perhaps facilitated by their greater proximity to the transducing electrical field generated by electroporation. Yet, overall, the contribution of electroporation, when isolated from the other experimental parameters, to the RNAi effect is relatively minor, and consequently could be omitted as an operational parameter when streamlining larger-scale screens with dsRNA. We note, however, that what may apply for optimal delivery of long dsRNA may not be the case for siRNA.</p>
<fig id="pntd-0000850-g009" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0000850.g009</object-id><label>Figure 9</label><caption>
<title>Electroporation is not necessary for maximal RNAi in newly transformed schistosomula.</title>
<p>Parasites were exposed to 30 µg/ml dsRNA for representative gut (SmCB1), tegument (SmCB2) and otherwise (SmMetAP) targets and then incubated for 6 days. Experimental parameters were as follows: E+S, electroporation with dsRNA followed by soaking (i.e., co-incubation with dsRNA); E+W, electroporation with dsRNA then washing worms 10 times to remove extraneous dsRNA and followed by soaking; E/S, electroporation without dsRNA and then soaking in the presence of dsRNA; S, soaking with dsRNA without prior electroporation. RNAi was measured by qRT-PCR and data expressed relative to those following parasite exposure to schistosome-unspecific mCherry dsRNA. Simple soaking of dsRNA targeting either SmCB1 (A) or SmMetAP (C) was sufficient to achieve maximal RNAi; electroporation had a minor effect. In contrast, for the tegumental protease, SmCB2, (B) (also for SmAx and Sm29, not shown), electroporation mediated a greater effect, but still not as pronounced as that produced by simple co-incubation. In both (B) and (C), levels of SmCB1 transcript, employed as a ‘tissue control’, were unaffected. Each sample was tested in duplicate and representative data from two experiments are shown.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000850.g009" xlink:type="simple"/></fig></sec><sec id="s3f">
<title>The gut as a mediator of RNAi in newly transformed schistosomula</title>
<p>Given the above data suggesting that simple co-incubation of newly transformed parasites and dsRNA is sufficient to mediate RNAi, we then asked the question whether the gut serves as a route of entry for dsRNA into the schistosome. The question is relevant in view of previous discussions to the effect that the parasite mouth is not open until about day 7 of the incubation (i.e., indicative of a non-functioning gut) and, therefore, cannot facilitate RNAi in younger schistosomula <xref ref-type="bibr" rid="pntd.0000850-KrautzPeterson4">[96]</xref>. Using Cy5-labeled dsRNA to CB1, CC or mCherry, we demonstrate that the gut of schistosomula takes up and concentrates exogenous material within minutes of their mechanical preparation (<xref ref-type="fig" rid="pntd-0000850-g010">Figure 10</xref>; results with CB1 dsRNA shown). Accumulation of the dye was evident along the gut and in the two terminal cecal chambers by 90 min post-transformation (<xref ref-type="fig" rid="pntd-0000850-g010">Figure 10A</xref>). At the same time-point, a fluorescent signal from accumulated mCherry protein could be detected (<xref ref-type="fig" rid="pntd-0000850-g010">Figure 10B</xref>). For both probes, the signal remained visible during the incubation period of 6 days illuminating the gut ceca as they elongated posteriorly over time. Consistent with this rapid onset of gut activity, we could already measure RNAi of CB1 at between 2 and 4 h post-incubation with dsRNA, an effect that increased as a function of time (<xref ref-type="fig" rid="pntd-0000850-g003">Figure 3B</xref>). Finally, we could detect hemoglobin-derived pigment in the gut of 2 day-old schistosomula co-incubated with erythrocytes (<xref ref-type="fig" rid="pntd-0000850-g010">Figure 10C</xref>). Taken together, the results suggest that the schistosomulum gut is functionally active within minutes of their preparation from cercariae and seems a likely route through which RNAi is mediated.</p>
<fig id="pntd-0000850-g010" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0000850.g010</object-id><label>Figure 10</label><caption>
<title>The gut of newly transformed schistosomula is active and likely facilitates RNAi.</title>
<p>After their preparation from cercariae, schistosomula were incubated with (A) 30 µg/ml Cy5-linked dsRNA targeting SmCB1, (B) 200 µg/ml recombinant mCherry protein or (C) 5 µl washed and packed human erythrocytes. For each image, the anterior end of the parasite is leftmost and times stated are post-preparation from cercariae. Both the Cy5-linked dsRNA and mCherry emit a strong fluorescent signal that quickly accumulates in the gut including in the two terminal cecal chambers. The arrow and arrowheads indicate the acetabular ‘gland ducts’ and acetabular ‘glands’, both being distinct from the developing gut. In (C), brown material, derived from the digestion of hemoglobin, highlights the parasite gut. Images were captured using: (A) a Zeiss LSM 510 META confocal microscope and a 633 nm laser for excitation; (B) a Zeiss Axiovert 40 CFL inverted microscope using the Filter Set 20 (ex-546; em-575-640) and connected to a Zeiss AxioCam HRc digital camera and (C) a Zeiss Axiovert 40 C inverted microscope connected to a Zeiss AxioCam MRc. Both AxioCAms were operated by AxioVision 40, version 4.5.0.0, software. Scale bars represent 20 µm.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000850.g010" xlink:type="simple"/></fig></sec></sec><sec id="s4">
<title>Discussion</title>
<p>Large-scale RNA-dependent gene silencing is an informative reverse genetic platform to interrogate decreased or loss of gene function at the protein, pathway, cell and organism levels. RNAi can also aid the identification of drug targets for the treatment of a variety of disease states <xref ref-type="bibr" rid="pntd.0000850-Kiefer1">[99]</xref>, <xref ref-type="bibr" rid="pntd.0000850-MacKeigan1">[100]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Perrimon1">[101]</xref>, including those caused by pathogens <xref ref-type="bibr" rid="pntd.0000850-Cherry1">[102]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Prudencio1">[103]</xref>. For schistosomes, a number of key components (comprehensive genome and transcriptome data, interrogable databases, and both <italic>in silico</italic> and experimental evidence of the RNAi phenomenon) are now in place to facilitate the implementation of larger scale RNAi-based screening campaigns.</p>
<p>In advance, we investigated the sensitivity and selectivity of RNAi for a set of 11 genes, which contained representatives from different tissue types – gut, tegument and otherwise. We employed long (approximately 500 bp) dsRNA rather than siRNA as the former can be produced at scales sufficient for performing multiple experiments and based on the assumption that the variety of siRNAs generated from the parent dsRNA would provide for as much silencing potential as possible. We focused on mechanically transformed schistosomula that are both relevant to parasitism in humans and, compared to adult parasites, available in greater numbers for automated high throughput screening <xref ref-type="bibr" rid="pntd.0000850-Abdulla2">[76]</xref>. In addition, issues of operational efficiency and simplicity were also considered, including, choice of culture medium, transfection strategy, dsRNA time- and dose-dependency and dosing limits. It was during these studies that the gut was identified as a likely route for entry of dsRNA into the newly transformed parasite.</p>
<p>The question of which culture medium to use for optimal maintenance of schistosomula has not been directly evaluated since the pioneering culture work of Cheever and Weller, and Clegg in the 1950s and 60s <xref ref-type="bibr" rid="pntd.0000850-Cheever1">[104]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Clegg1">[105]</xref>, and Basch in the early 1980's <xref ref-type="bibr" rid="pntd.0000850-Basch1">[78]</xref>. The issue is also relevant to chemical drug discovery programs that involve co-incubation of schistosomula with compounds and the recording of phenotypes <xref ref-type="bibr" rid="pntd.0000850-Abdulla2">[76]</xref>. Of the seven media tested here (Basch Medium 169, DMEM, F-12, Liebowitz's, M199, RPMI 1640 and Schneider's), all except Basch Medium 169 induced abnormal phenotypes amounting to darkened and/or distorted parasites often accompanied by slowed and less dynamic motility. In the case of Schneider's and RPMI 1640 media, widespread death occurred. Of note was the poor survival of schistosomula in RPMI 1640, a medium that has been previously employed for a number of RNAi studies with schistosomula <xref ref-type="bibr" rid="pntd.0000850-Skelly1">[52]</xref>, <xref ref-type="bibr" rid="pntd.0000850-KrautzPeterson2">[65]</xref>, <xref ref-type="bibr" rid="pntd.0000850-KrautzPeterson4">[96]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Ndegwa1">[98]</xref>. Our concern was that the high background mortality observed here would make determinations of an RNAi effect, either at the mRNA level or, certainly, at the phenotypic level, difficult. Yet, despite the poor survival in RPMI, RNAi of CB1 transcript could be decreased to levels similar to those achieved in Basch Medium 169 (data not shown) - a finding consistent with the effect observed previously. Nevertheless, based on the present media tests, we employ Basch Medium 169 as the medium of choice for maintenance of <italic>S. mansoni</italic> schistosomula as mortality remained at approximately 10% out to 4 weeks of incubation. Indeed, consistent with the earlier report <xref ref-type="bibr" rid="pntd.0000850-Basch1">[78]</xref>, we have been able to maintain parasites long enough (about 8 months) in Basch Complete Medium 169 to the point of pairing of males and females (unpublished data).</p>
<p>Key concerns in any large scale screening campaign are the occurrence and extent of off-targeting. The possibility of such phenomena operating in schistosomes has been raised in a recent report involving RNAi of 32 genes expressed in <italic>S. mansoni</italic> mother sporocysts <xref ref-type="bibr" rid="pntd.0000850-deMoraesMouro1">[74]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Mouro1">[75]</xref>. For the smaller set of 11 genes studied here in schistosomula, we did not observe off-targeting which is encouraging for larger scale studies. RNAi, including suppression of more than one transcript, was selective to the intended target(s) among and between the different pools of gut, tegument and generally distributed transcripts investigated. The finding is also important as it expands upon previous data for smaller numbers (1 to 3) of genes of interest <xref ref-type="bibr" rid="pntd.0000850-Morales1">[55]</xref>, <xref ref-type="bibr" rid="pntd.0000850-KrautzPeterson2">[65]</xref> that demonstrated RNAi specificity relative to schistosome-unspecific dsRNA preparations used as controls. The apparent lack of off-targeting in newly transformed schistosomula is consistent with data from similarly designed experiments for a pool of gut-associated proteases in 3-week old <italic>S. mansoni</italic> <xref ref-type="bibr" rid="pntd.0000850-Delcroix1">[54]</xref>. That the contemporaneous and selective suppression of more than one gene is possible in schistosomula could prove useful in interrogating functional redundancy within protein systems. An example of such is the network of gut proteases that digest host proteins <xref ref-type="bibr" rid="pntd.0000850-Delcroix1">[54]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Caffrey3">[79]</xref>. Multiple RNAi of component proteases may help reveal the extent of redundancy and highlight cooperative relationships in how host proteins are processed.</p>
<p>For both the gut and tegument genes studied, knockdown efficiency, including after double-targeting, was at least 75%. For the gut proteases, CC and CB1, transcript knockdown was mirrored by a substantial decrease or loss of translation product as determined biochemically with a specific substrate and active site-directed probe for CC, and a monospecific anti-serum to CB1. The robust suppression of CB1 and CD recorded here is consistent with previous studies using schistosomula <xref ref-type="bibr" rid="pntd.0000850-Correnti1">[53]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Morales1">[55]</xref>, <xref ref-type="bibr" rid="pntd.0000850-KrautzPeterson4">[96]</xref> and 3 week-old sub-adult worms <xref ref-type="bibr" rid="pntd.0000850-Delcroix1">[54]</xref>. Though our observations did not include measurements of worm size to statistically discriminate dsRNA-induced phenotypic alterations <xref ref-type="bibr" rid="pntd.0000850-Correnti1">[53]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Morales1">[55]</xref>, we noted no striking abnormalities in parasites co-incubated for 3 weeks with dsRNA to CB1 and/or CD in the presence or absence of erythrocytes. This included a previous observation of red-colored, rather than the normally black, gut contents in a population of schistosomula exposed to CD-dsRNA in the presence of erythrocytes– a finding that prompted the suggestion that diminished CD activity was responsible for the phenotype <xref ref-type="bibr" rid="pntd.0000850-Morales1">[55]</xref>. At this time, we cannot explain the difference in phenotypic outcomes, however, we observe that the color of gut contents of individual schistosomula normally varies from black to brown to red when cultured in the presence of erythrocytes.</p>
<p>The robust RNAi of gut and tegument targets contrasts with the more variable efficiencies recorded for the 5 gene targets considered to be more generally distributed in the parasite and that had been predicted <italic>in silico</italic> to be essential <xref ref-type="bibr" rid="pntd.0000850-Caffrey2">[46]</xref>. Thus, the efficiency of RNAi ranged from approximately 75% (MetAP) to approximately 40% for GSK3 and NEC. We speculate that the localization of gene expression is in part responsible for this variation whereby genes expressed in the gut and tegument are more likely to be efficiently suppressed given their proximity to the external environment containing dsRNA.</p>
<p>Such gene-to-gene variability in sensitivity to RNAi is likely inherent when, under a standardized set of conditions such as those under investigation here, not all gene transcripts will respond to the same degree. Variable gene responses to RNAi have also been recently described for <italic>S. mansoni</italic> mother sporocysts <xref ref-type="bibr" rid="pntd.0000850-deMoraesMouro1">[74]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Mouro1">[75]</xref> and schistosomula <xref ref-type="bibr" rid="pntd.0000850-KrautzPeterson2">[65]</xref> exposed to dsRNA. Transcripts not decreased below certain critical thresholds will contribute to the lack of obvious phenotypes arising. This could also explain why targeting the 5 genes that had been predicted <italic>in silico</italic> as being essential to <italic>S. mansoni</italic> <xref ref-type="bibr" rid="pntd.0000850-Caffrey2">[46]</xref> produced no gross phenotypic alterations, even at near toxic dsRNA concentrations or over an extended 3-week co-incubation period. Of course, this is aside from the more direct possibility that the genes are not, after all, essential to survival of the parasite or the particular developmental stage in question. In addition, and as discussed previously <xref ref-type="bibr" rid="pntd.0000850-Boyle1">[51]</xref>, even for genes that are sensitive to RNAi, issues such as developmental plasticity of the schistosome and functional redundancy in protein function, pathways or networks will limit the number of readily observable phenotypes. Yet, given these considerations, literature reports of striking phenotypes post-RNAi in schistosomula (e.g., <xref ref-type="bibr" rid="pntd.0000850-Faghiri1">[59]</xref>, <xref ref-type="bibr" rid="pntd.0000850-Kuntz1">[63]</xref>) would encourage continued loss-of-function investigations, especially in view of the imperative to identify new drug targets.</p>
<p>The finding that co-incubation of newly transformed parasites and dsRNA, without the need for electroporation (i.e., trans-tegumental delivery of dsRNA), is sufficient to induce robust RNAi focused our attention on the parasite gut in dsRNA uptake. By 90 min post-production from cercariae we could observe a concentration of fluorescent macromolecules above background in the gut that was indicative of rapid and active ingestion of exogenous material by the parasite. This gut activity during transformation from the cercarial state is consistent with electron microscopy studies demonstrating rearrangements of the esophageal environment <xref ref-type="bibr" rid="pntd.0000850-Cousin1">[106]</xref> and earlier observations that transforming parasites engulf culture fluid <xref ref-type="bibr" rid="pntd.0000850-Jensen1">[107]</xref>. In parallel with the ingestion of fluorescent materials, we could measure decreased CB1 transcript 2 to 4 hours after co-incubation of worms with specific dsRNA suggesting that dsRNA, upon ingestion, is both rapidly absorbed and processed to initiate mRNA suppression. It is possible that the tegument or other organ systems such as the acetabular glands <xref ref-type="bibr" rid="pntd.0000850-KrautzPeterson4">[96]</xref> or nephridiopore <xref ref-type="bibr" rid="pntd.0000850-Thornhill1">[108]</xref> also act as entry points for dsRNA in nascent schistosomula, however, the present results suggest that the gut should also be considered as a key contributor. Finally, the observation of blood products in 2 day-old schistosomula reinforces the evidence that the gut is quickly put to work by the parasite in the acquisition of nutrients.</p>
<p>The data reported herein that newly transformed schistosomula are amenable to RNAi is promising in view of previous reports observing less efficient or inconsistent suppression (of CB1) in parasites &lt;7days old <xref ref-type="bibr" rid="pntd.0000850-Correnti1">[53]</xref>, <xref ref-type="bibr" rid="pntd.0000850-KrautzPeterson4">[96]</xref>. The underlying reasons for these apparent differences in RNAi kinetics are unclear and could be reviewed as part of a broader discussion on assay development and refinement. From the perspective of screen design, however, it is logistically much simpler to move directly from ‘snails to screens’ employing newly transformed schistosomula without factoring for both the extra time and handling required for older parasites, particularly as they seem to be more susceptible to handling damage than newly transformed schistosomula (unpublished data).</p>
</sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pntd.0000850.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000850.s001" xlink:type="simple"><label>Figure S1</label><caption>
<p>The influence of qPCR primer positioning on the amplification of residual PCR product carried over from dsRNA synthesis. There is no amplification of residual PCR product (Panel A) when primer pairs (Primer set A) are positioned upstream from that part of the open reading frame of SmCB2 used to synthesize dsRNA (Panel B). In contrast, Primer set B (positioned within the sequence used to generate dsRNA) amplifies residual PCR product in a concentration-dependent manner that would negatively impact the apparent efficiency of RNAi as measured by qRT-PCR. Each sample was tested in duplicate and representative data from two experiments are shown.</p>
<p>(0.35 MB TIF)</p>
</caption></supplementary-material><supplementary-material id="pntd.0000850.s002" mimetype="application/x-excel" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000850.s002" xlink:type="simple"><label>Table S1</label><caption>
<p>List of primer sequences employed for dsRNA synthesis (the T7 DNA polymerase binding motif is shown in bold characters) and quantitative real-time (qRT)-PCR.</p>
<p>(0.03 MB XLS)</p>
</caption></supplementary-material><supplementary-material id="pntd.0000850.s003" mimetype="video/quicktime" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000850.s003" xlink:type="simple"><label>Video S1</label><caption>
<p>Phenotypic responses of <italic>S. mansoni</italic> schistosomula upon incubation in Basch Medium 169. Parasites were maintained for 7 days in medium containing 5% FBS, and 100 U/ml penicillin and 100 µg/ml streptomycin. Time-lapse recordings were captured with a Zeiss Axiovert 40 C inverted microscope (10× magnification) connected to a Zeiss AxioCam MRc digital camera that was under the control of AxioVision 40 version 4.5.0.0 software. Note that parasites in this medium appear most uniform in translucency, shape and motion with the least background mortality.</p>
<p>(3.66 MB MOV)</p>
</caption></supplementary-material><supplementary-material id="pntd.0000850.s004" mimetype="video/quicktime" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000850.s004" xlink:type="simple"><label>Video S2</label><caption>
<p>Phenotypic responses of <italic>S. mansoni</italic> schistosomula upon incubation in DMEM (high glucose) medium. Parasites were maintained for 7 days in medium containing 5% FBS, and 100 U/ml penicillin and 100 µg/ml streptomycin. Time-lapse recordings were captured with a Zeiss Axiovert 40 C inverted microscope (10× magnification) connected to a Zeiss AxioCam MRc digital camera that was under the control of AxioVision 40 version 4.5.0.0 software.</p>
<p>(3.53 MB MOV)</p>
</caption></supplementary-material><supplementary-material id="pntd.0000850.s005" mimetype="video/quicktime" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000850.s005" xlink:type="simple"><label>Video S3</label><caption>
<p>Phenotypic responses of <italic>S. mansoni</italic> schistosomula upon incubation in F-12 medium. Parasites were maintained for 7 days in medium containing 5% FBS, and 100 U/ml penicillin and 100 µg/ml streptomycin. Time-lapse recordings were captured with a Zeiss Axiovert 40 C inverted microscope (10× magnification) connected to a Zeiss AxioCam MRc digital camera that was under the control of AxioVision 40 version 4.5.0.0 software.</p>
<p>(3.47 MB MOV)</p>
</caption></supplementary-material><supplementary-material id="pntd.0000850.s006" mimetype="video/quicktime" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000850.s006" xlink:type="simple"><label>Video S4</label><caption>
<p>Phenotypic responses of <italic>S. mansoni</italic> schistosomula upon incubation in Liebowitz's medium. Parasites were maintained for 7 days in medium containing 5% FBS, and 100 U/ml penicillin and 100 µg/ml streptomycin. Time-lapse recordings were captured with a Zeiss Axiovert 40 C inverted microscope (10× magnification) connected to a Zeiss AxioCam MRc digital camera that was under the control of AxioVision 40 version 4.5.0.0 software.</p>
<p>(3.44 MB MOV)</p>
</caption></supplementary-material><supplementary-material id="pntd.0000850.s007" mimetype="video/quicktime" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000850.s007" xlink:type="simple"><label>Video S5</label><caption>
<p>Phenotypic responses of <italic>S. mansoni</italic> schistosomula upon incubation in M199 medium with Earle's Salts. Parasites were maintained for 7 days in medium containing 5% FBS, and 100 U/ml penicillin and 100 µg/ml streptomycin. Time-lapse recordings were captured with a Zeiss Axiovert 40 C inverted microscope (10× magnification) connected to a Zeiss AxioCam MRc digital camera that was under the control of AxioVision 40 version 4.5.0.0 software.</p>
<p>(4.30 MB MOV)</p>
</caption></supplementary-material><supplementary-material id="pntd.0000850.s008" mimetype="video/quicktime" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000850.s008" xlink:type="simple"><label>Video S6</label><caption>
<p>Phenotypic responses of <italic>S. mansoni</italic> schistosomula upon incubation in RPMI 1640 medium. Parasites were maintained for 7 days in medium containing 10 mM HEPES, 2 mM glutamine, 5% FBS, and 100 U/ml penicillin and 100 µg/ml streptomycin. Time-lapse recordings were captured with a Zeiss Axiovert 40 C inverted microscope (10× magnification) connected to a Zeiss AxioCam MRc digital camera that was under the control of AxioVision 40 version 4.5.0.0 software.</p>
<p>(2.81 MB MOV)</p>
</caption></supplementary-material><supplementary-material id="pntd.0000850.s009" mimetype="video/quicktime" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000850.s009" xlink:type="simple"><label>Video S7</label><caption>
<p>Phenotypic responses of <italic>S. mansoni</italic> schistosomula upon incubation in Schneider's medium. Parasites were maintained for 7 days in medium containing 5% FBS, and 100 U/ml penicillin and 100 µg/ml streptomycin. Time-lapse recordings were captured with a Zeiss Axiovert 40 C inverted microscope (10× magnification) connected to a Zeiss AxioCam MRc digital camera that was under the control of AxioVision 40 version 4.5.0.0 software.</p>
<p>(2.63 MB MOV)</p>
</caption></supplementary-material></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pntd.0000850-Hotez1"><label>1</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hotez</surname><given-names>PJ</given-names></name>
<name name-style="western"><surname>Fenwick</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Savioli</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Molyneux</surname><given-names>DH</given-names></name>
</person-group>             <year>2009</year>             <article-title>Rescuing the bottom billion through control of neglected tropical diseases.</article-title>             <source>Lancet</source>             <volume>373</volume>             <fpage>1570</fpage>             <lpage>1575</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Vieira1"><label>2</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Vieira</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Miranda</surname><given-names>HP</given-names></name>
<name name-style="western"><surname>Cerqueira</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Delgado Mde</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Coelho</surname><given-names>H</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Latent schistosomiasis in Portuguese soldiers.</article-title>             <source>Mil Med</source>             <volume>172</volume>             <fpage>144</fpage>             <lpage>146</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Bell1"><label>3</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Bell</surname><given-names>RM</given-names></name>
<name name-style="western"><surname>Daly</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Kanengoni</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Jones</surname><given-names>JJ</given-names></name>
</person-group>             <year>1973</year>             <article-title>The effects of endemic schistosomiasis and of hycanthone on the mental ability of African school children.</article-title>             <source>Trans R Soc Trop Med Hyg</source>             <volume>67</volume>             <fpage>694</fpage>             <lpage>701</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Gryseels1"><label>4</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Gryseels</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Polman</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Clerinx</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Kestens</surname><given-names>L</given-names></name>
</person-group>             <year>2006</year>             <article-title>Human schistosomiasis.</article-title>             <source>Lancet</source>             <volume>368</volume>             <fpage>1106</fpage>             <lpage>1118</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Hotez2"><label>5</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hotez</surname><given-names>PJ</given-names></name>
<name name-style="western"><surname>Fenwick</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Kjetland</surname><given-names>EF</given-names></name>
</person-group>             <year>2009</year>             <article-title>Africa's 32 Cents Solution for HIV/AIDS.</article-title>             <source>PLoS Negl Trop Dis</source>             <volume>3</volume>             <fpage>e430</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Jukes1"><label>6</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Jukes</surname><given-names>MC</given-names></name>
<name name-style="western"><surname>Nokes</surname><given-names>CA</given-names></name>
<name name-style="western"><surname>Alcock</surname><given-names>KJ</given-names></name>
<name name-style="western"><surname>Lambo</surname><given-names>JK</given-names></name>
<name name-style="western"><surname>Kihamia</surname><given-names>C</given-names></name>
<etal/></person-group>             <year>2002</year>             <article-title>Heavy schistosomiasis associated with poor short-term memory and slower reaction times in Tanzanian schoolchildren.</article-title>             <source>Trop Med Int Health</source>             <volume>7</volume>             <fpage>104</fpage>             <lpage>117</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Wu1"><label>7</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Wu</surname><given-names>XH</given-names></name>
<name name-style="western"><surname>Wang</surname><given-names>TP</given-names></name>
<name name-style="western"><surname>Lu</surname><given-names>DB</given-names></name>
<name name-style="western"><surname>Hu</surname><given-names>HT</given-names></name>
<name name-style="western"><surname>Gao</surname><given-names>ZB</given-names></name>
<etal/></person-group>             <year>2002</year>             <article-title>Studies of impact on physical fitness and working capacity of patients with advanced Schistosomiasis japonica in Susong County, Anhui Province.</article-title>             <source>Acta Trop</source>             <volume>82</volume>             <fpage>247</fpage>             <lpage>252</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Badawi1"><label>8</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Badawi</surname><given-names>AF</given-names></name>
<name name-style="western"><surname>Mostafa</surname><given-names>MH</given-names></name>
<name name-style="western"><surname>Probert</surname><given-names>A</given-names></name>
<name name-style="western"><surname>O'Connor</surname><given-names>PJ</given-names></name>
</person-group>             <year>1995</year>             <article-title>Role of schistosomiasis in human bladder cancer: evidence of association, aetiological factors, and basic mechanisms of carcinogenesis.</article-title>             <source>Eur J Cancer Prev</source>             <volume>4</volume>             <fpage>45</fpage>             <lpage>59</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Rollinson1"><label>9</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Rollinson</surname><given-names>D</given-names></name>
</person-group>             <year>2009</year>             <article-title>A wake up call for urinary schistosomiasis: reconciling research effort with public health importance.</article-title>             <source>Parasitology</source>             <volume>136</volume>             <fpage>1593</fpage>             <lpage>1610</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Kjetland1"><label>10</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kjetland</surname><given-names>EF</given-names></name>
<name name-style="western"><surname>Ndhlovu</surname><given-names>PD</given-names></name>
<name name-style="western"><surname>Gomo</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Mduluza</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Midzi</surname><given-names>N</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Association between genital schistosomiasis and HIV in rural Zimbabwean women.</article-title>             <source>AIDS</source>             <volume>20</volume>             <fpage>593</fpage>             <lpage>600</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Caffrey1"><label>11</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Caffrey</surname><given-names>CR</given-names></name>
</person-group>             <year>2007</year>             <article-title>Chemotherapy of schistosomiasis: present and future.</article-title>             <source>Current Opinion in Chemical Biology</source>             <volume>11</volume>             <fpage>433</fpage>             <lpage>439</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Cioli1"><label>12</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Cioli</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Pica-Mattoccia</surname><given-names>L</given-names></name>
</person-group>             <year>2003</year>             <article-title>Praziquantel.</article-title>             <source>Parasitol Res</source>             <volume>90</volume>      <supplement>Supp 1</supplement>       <fpage>S3</fpage>             <lpage>9</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Doenhoff1"><label>13</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Doenhoff</surname><given-names>MJ</given-names></name>
<name name-style="western"><surname>Pica-Mattoccia</surname><given-names>L</given-names></name>
</person-group>             <year>2006</year>             <article-title>Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance.</article-title>             <source>Expert Rev Anti Infect Ther</source>             <volume>4</volume>             <fpage>199</fpage>             <lpage>210</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Doenhoff2"><label>14</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Doenhoff</surname><given-names>MJ</given-names></name>
<name name-style="western"><surname>Hagan</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Cioli</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Southgate</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Pica-Mattoccia</surname><given-names>L</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs.</article-title>             <source>Parasitology</source>             <volume>136</volume>             <fpage>1825</fpage>             <lpage>1835</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Botros1"><label>15</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Botros</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Sayed</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Amer</surname><given-names>N</given-names></name>
<name name-style="western"><surname>El-Ghannam</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Bennett</surname><given-names>JL</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt.</article-title>             <source>Int J Parasitol</source>             <volume>35</volume>             <fpage>787</fpage>             <lpage>791</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Melman1"><label>16</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Melman</surname><given-names>SD</given-names></name>
<name name-style="western"><surname>Steinauer</surname><given-names>ML</given-names></name>
<name name-style="western"><surname>Cunningham</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Kubatko</surname><given-names>LS</given-names></name>
<name name-style="western"><surname>Mwangi</surname><given-names>IN</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of <italic>Schistosoma mansoni</italic>.</article-title>             <source>PLoS Negl Trop Dis</source>             <volume>3</volume>             <fpage>e504</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Smits1"><label>17</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Smits</surname><given-names>HL</given-names></name>
</person-group>             <year>2009</year>             <article-title>Prospects for the control of neglected tropical diseases by mass drug administration.</article-title>             <source>Expert Review of Anti-infective Therapy</source>             <volume>7</volume>             <fpage>37</fpage>             <lpage>56</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Brady1"><label>18</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Brady</surname><given-names>MA</given-names></name>
<name name-style="western"><surname>Hooper</surname><given-names>PJ</given-names></name>
<name name-style="western"><surname>Ottesen</surname><given-names>EA</given-names></name>
</person-group>             <year>2006</year>             <article-title>Projected benefits from integrating NTD programs in sub-Saharan Africa.</article-title>             <source>Trends Parasitol</source>             <volume>22</volume>             <fpage>285</fpage>             <lpage>291</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Hotez3"><label>19</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hotez</surname><given-names>PJ</given-names></name>
<name name-style="western"><surname>Molyneux</surname><given-names>DH</given-names></name>
<name name-style="western"><surname>Fenwick</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Ottesen</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Ehrlich Sachs</surname><given-names>S</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria.</article-title>             <source>PLoS Med</source>             <volume>3</volume>             <fpage>e102</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Lammie1"><label>20</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lammie</surname><given-names>PJ</given-names></name>
<name name-style="western"><surname>Fenwick</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Utzinger</surname><given-names>J</given-names></name>
</person-group>             <year>2006</year>             <article-title>A blueprint for success: integration of neglected tropical disease control programmes.</article-title>             <source>Trends Parasitol</source>             <volume>22</volume>             <fpage>313</fpage>             <lpage>321</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Molyneux1"><label>21</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Molyneux</surname><given-names>DH</given-names></name>
<name name-style="western"><surname>Hotez</surname><given-names>PJ</given-names></name>
<name name-style="western"><surname>Fenwick</surname><given-names>A</given-names></name>
</person-group>             <year>2005</year>             <article-title>“Rapid-impact interventions”: how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor.</article-title>             <source>PLoS Med</source>             <volume>2</volume>             <fpage>e336</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Utzinger1"><label>22</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Utzinger</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Raso</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Brooker</surname><given-names>S</given-names></name>
<name name-style="western"><surname>De Savigny</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Tanner</surname><given-names>M</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution.</article-title>             <source>Parasitology</source>             <volume>136</volume>             <fpage>1859</fpage>             <lpage>1874</lpage>          </element-citation></ref>
<ref id="pntd.0000850-AbdulGhani1"><label>23</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Abdul-Ghani</surname><given-names>RA</given-names></name>
<name name-style="western"><surname>Loutfy</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Hassan</surname><given-names>A</given-names></name>
</person-group>             <year>2009</year>             <article-title>Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use.</article-title>             <source>Parasitol Res</source>             <volume>105</volume>             <fpage>899</fpage>             <lpage>906</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Abdulla1"><label>24</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Abdulla</surname><given-names>MH</given-names></name>
<name name-style="western"><surname>Lim</surname><given-names>KC</given-names></name>
<name name-style="western"><surname>Sajid</surname><given-names>M</given-names></name>
<name name-style="western"><surname>McKerrow</surname><given-names>JH</given-names></name>
<name name-style="western"><surname>Caffrey</surname><given-names>CR</given-names></name>
</person-group>             <year>2007</year>             <article-title>Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor.</article-title>             <source>PLoS Med</source>             <volume>4</volume>             <fpage>e14</fpage>          </element-citation></ref>
<ref id="pntd.0000850-CorraSoares1"><label>25</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Corrêa Soares</surname><given-names>JB</given-names></name>
<name name-style="western"><surname>Menezes</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Vannier-Santos</surname><given-names>MA</given-names></name>
<name name-style="western"><surname>Ferreira-Pereira</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Almeida</surname><given-names>GT</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Interference with hemozoin formation represents an important mechanism of schistosomicidal action of antimalarial quinoline methanols.</article-title>             <source>PLoS Negl Trop Dis</source>             <volume>3</volume>             <fpage>e477</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Keiser1"><label>26</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Keiser</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Utzinger</surname><given-names>J</given-names></name>
</person-group>             <year>2007</year>             <article-title>Advances in the discovery and development of trematocidal drugs.</article-title>             <source>Expert Opin Drug Discov</source>             <volume>2</volume>             <supplement>Suppl. 1</supplement>             <fpage>S9</fpage>             <lpage>S23</lpage>          </element-citation></ref>
<ref id="pntd.0000850-McManus1"><label>27</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>McManus</surname><given-names>DP</given-names></name>
<name name-style="western"><surname>Loukas</surname><given-names>A</given-names></name>
</person-group>             <year>2008</year>             <article-title>Current status of vaccines for schistosomiasis.</article-title>             <source>Clin Microbiol Rev</source>             <volume>21</volume>             <fpage>225</fpage>             <lpage>242</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Fitzpatrick1"><label>28</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Fitzpatrick</surname><given-names>JM</given-names></name>
<name name-style="western"><surname>Peak</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Perally</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Chalmers</surname><given-names>IW</given-names></name>
<name name-style="western"><surname>Barrett</surname><given-names>J</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Anti-schistosomal intervention targets identified by lifecycle transcriptomic analyses.</article-title>             <source>PLoS Negl Trop Dis</source>             <volume>3</volume>             <fpage>e543</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Gobert1"><label>29</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Gobert</surname><given-names>GN</given-names></name>
<name name-style="western"><surname>Moertel</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Brindley</surname><given-names>PJ</given-names></name>
<name name-style="western"><surname>McManus</surname><given-names>DP</given-names></name>
</person-group>             <year>2009</year>             <article-title>Developmental gene expression profiles of the human pathogen <italic>Schistosoma japonicum</italic>.</article-title>             <source>BMC Genomics</source>             <volume>10</volume>             <fpage>128</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Jolly1"><label>30</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Jolly</surname><given-names>ER</given-names></name>
<name name-style="western"><surname>Chin</surname><given-names>CS</given-names></name>
<name name-style="western"><surname>Miller</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Baghat</surname><given-names>MM</given-names></name>
<name name-style="western"><surname>Lim</surname><given-names>KC</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Gene expression patterns during adaptation of a parasite helminth to different environmental niches.</article-title>             <source>Genome Biol</source>             <volume>8</volume>             <fpage>R65</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Liu1"><label>31</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Liu</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Lu</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Hu</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Wang</surname><given-names>SY</given-names></name>
<name name-style="western"><surname>Cui</surname><given-names>SJ</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>New perspectives on host-parasite interplay by comparative transcriptomic and proteomic analyses of <italic>Schistosoma japonicum</italic>.</article-title>             <source>PLoS Pathog</source>             <volume>2</volume>             <fpage>e29</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Oliveira1"><label>32</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Oliveira</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Franco</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Verjovski-Almeida</surname><given-names>S</given-names></name>
</person-group>             <year>2008</year>             <article-title>The Brazilian contribution to the study of the <italic>Schistosoma mansoni</italic> transcriptome.</article-title>             <source>Acta Trop</source>             <volume>108</volume>             <fpage>179</fpage>             <lpage>182</lpage>          </element-citation></ref>
<ref id="pntd.0000850-VerjovskiAlmeida1"><label>33</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Verjovski-Almeida</surname><given-names>S</given-names></name>
<name name-style="western"><surname>DeMarco</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Martins</surname><given-names>EA</given-names></name>
<name name-style="western"><surname>Guimarães</surname><given-names>PE</given-names></name>
<name name-style="western"><surname>Ojopi</surname><given-names>EP</given-names></name>
<etal/></person-group>             <year>2003</year>             <article-title>Transcriptome analysis of the acoelomate human parasite <italic>Schistosoma mansoni</italic>.</article-title>             <source>Nat Genet</source>             <volume>35</volume>             <fpage>148</fpage>             <lpage>157</lpage>          </element-citation></ref>
<ref id="pntd.0000850-VerjovskiAlmeida2"><label>34</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Verjovski-Almeida</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Venancio</surname><given-names>TM</given-names></name>
<name name-style="western"><surname>Oliveira</surname><given-names>KC</given-names></name>
<name name-style="western"><surname>Almeida</surname><given-names>GT</given-names></name>
<name name-style="western"><surname>Demarco</surname><given-names>R</given-names></name>
</person-group>             <year>2007</year>             <article-title>Use of a 44k oligoarray to explore the transcriptome of <italic>Schistosoma mansoni</italic> adult worms.</article-title>             <source>Exp Parasitol</source>             <volume>117</volume>             <fpage>236</fpage>             <lpage>245</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Williams1"><label>35</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Williams</surname><given-names>DL</given-names></name>
<name name-style="western"><surname>Sayed</surname><given-names>AA</given-names></name>
<name name-style="western"><surname>Bernier</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Birkeland</surname><given-names>SR</given-names></name>
<name name-style="western"><surname>Cipriano</surname><given-names>MJ</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Profiling <italic>Schistosoma mansoni</italic> development using serial analysis of gene expression (SAGE).</article-title>             <source>Exp Parasitol</source>             <volume>117</volume>             <fpage>246</fpage>             <lpage>258</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Hu1"><label>36</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hu</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Yan</surname><given-names>Q</given-names></name>
<name name-style="western"><surname>Shen</surname><given-names>DK</given-names></name>
<name name-style="western"><surname>Liu</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Zhu</surname><given-names>ZD</given-names></name>
<etal/></person-group>             <year>2003</year>             <article-title>Evolutionary and biomedical implications of a <italic>Schistosoma japonicum</italic> complementary DNA resource.</article-title>             <source>Nat Genet</source>             <volume>35</volume>             <fpage>139</fpage>             <lpage>147</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Berriman1"><label>37</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Berriman</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Haas</surname><given-names>BJ</given-names></name>
<name name-style="western"><surname>LoVerde</surname><given-names>PT</given-names></name>
<name name-style="western"><surname>Wilson</surname><given-names>RA</given-names></name>
<name name-style="western"><surname>Dillon</surname><given-names>GP</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>The genome of the blood fluke <italic>Schistosoma mansoni</italic>.</article-title>             <source>Nature</source>             <volume>460</volume>             <fpage>352</fpage>             <lpage>358</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Liu2"><label>38</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Liu</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Wang</surname><given-names>ZQ</given-names></name>
<name name-style="western"><surname>Lu</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Zheng</surname><given-names>H</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>The <italic>Schistosoma japonicum</italic> genome reveals features of host-parasite interplay.</article-title>             <source>Nature</source>             <volume>460</volume>             <fpage>345</fpage>             <lpage>351</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Tsai1"><label>39</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Tsai</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Otto</surname><given-names>TD</given-names></name>
<name name-style="western"><surname>Berriman</surname><given-names>M</given-names></name>
</person-group>             <year>2010</year>             <article-title>Improving draft assemblies by iterative mapping and assembly of short reads to eliminate gaps.</article-title>             <source>Genome Biology</source>             <volume>11</volume>             <fpage>R41</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Liu3"><label>40</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Liu</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Chen</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Cui</surname><given-names>SJ</given-names></name>
<name name-style="western"><surname>Wang</surname><given-names>ZQ</given-names></name>
<name name-style="western"><surname>Han</surname><given-names>ZG</given-names></name>
</person-group>             <year>2008</year>             <article-title>SjTPdb: integrated transcriptome and proteome database and analysis platform for <italic>Schistosoma japonicum</italic>.</article-title>             <source>BMC Genomics</source>             <volume>9</volume>             <fpage>304</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Zerlotini1"><label>41</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Zerlotini</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Heiges</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Wang</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Moraes</surname><given-names>RL</given-names></name>
<name name-style="western"><surname>Dominitini</surname><given-names>AJ</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>SchistoDB: a <italic>Schistosoma mansoni</italic> genome resource.</article-title>             <source>Nucleic Acids Res</source>             <volume>37</volume>             <fpage>D579</fpage>             <lpage>582</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Agero1"><label>42</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Agüero</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Al-Lazikani</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Aslett</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Berriman</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Buckner</surname><given-names>FS</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>Genomic-scale prioritization of drug targets: the TDR Targets database.</article-title>             <source>Nat Rev Drug Discov</source>             <volume>7</volume>             <fpage>900</fpage>             <lpage>907</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Beckstette1"><label>43</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Beckstette</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Mailänder</surname><given-names>JT</given-names></name>
<name name-style="western"><surname>Marhöfer</surname><given-names>RJ</given-names></name>
<name name-style="western"><surname>Sczyrba</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Ohlebusch</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Giegerich</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Selzer</surname><given-names>PM</given-names></name>
</person-group>             <year>2004</year>             <article-title>Genlight: interactive high-throughput sequence analysis and comparative genomics.</article-title>             <source>Journal of Integrative Bioinformatics</source>             <volume>1</volume>          </element-citation></ref>
<ref id="pntd.0000850-Margulies1"><label>44</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Margulies</surname><given-names>EH</given-names></name>
<name name-style="western"><surname>Birney</surname><given-names>E</given-names></name>
</person-group>             <year>2008</year>             <article-title>Approaches to comparative sequence analysis: towards a functional view of vertebrate genomes.</article-title>             <source>Nat Rev Genet</source>             <volume>9</volume>             <fpage>303</fpage>             <lpage>313</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Ptacek1"><label>45</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ptacek</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Sell</surname><given-names>SM</given-names></name>
</person-group>             <year>2005</year>             <article-title>A tiered approach to comparative genomics.</article-title>             <source>Brief Funct Genomic Proteomic</source>             <volume>4</volume>             <fpage>178</fpage>             <lpage>185</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Caffrey2"><label>46</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Caffrey</surname><given-names>CR</given-names></name>
<name name-style="western"><surname>Rohwer</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Oellien</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Marhöfer</surname><given-names>RJ</given-names></name>
<name name-style="western"><surname>Braschi</surname><given-names>S</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>A comparative chemogenomics strategy to predict potential drug targets in the metazoan pathogen, <italic>Schistosoma mansoni</italic>.</article-title>             <source>PLoS ONE</source>             <volume>4</volume>             <fpage>e4413</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Brindley1"><label>47</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Brindley</surname><given-names>PJ</given-names></name>
<name name-style="western"><surname>Pearce</surname><given-names>EJ</given-names></name>
</person-group>             <year>2007</year>             <article-title>Genetic manipulation of schistosomes.</article-title>             <source>Int J Parasitol</source>             <volume>37</volume>             <fpage>465</fpage>             <lpage>473</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Dvok1"><label>48</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Dvořák</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Beckmann</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Lim</surname><given-names>KC</given-names></name>
<name name-style="western"><surname>Engel</surname><given-names>JC</given-names></name>
<name name-style="western"><surname>Grevelding</surname><given-names>CG</given-names></name>
<etal/></person-group>             <year>2010</year>             <article-title>Biolistic transformation of <italic>Schistosoma mansoni</italic>: Studies with modified reporter-gene constructs containing regulatory regions of protease genes.</article-title>             <source>Mol Biochem Parasitol</source>             <volume>170</volume>             <fpage>37</fpage>             <lpage>40</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Grevelding1"><label>49</label><element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Grevelding</surname><given-names>CG</given-names></name>
</person-group>             <year>2006</year>             <article-title>Transgenic flatworms.</article-title>             <person-group person-group-type="editor">
<name name-style="western"><surname>Maule</surname><given-names>AGMNJ</given-names></name>
</person-group>             <source>Parasitic flatworms: molecular biology, biochemistry, immunology and physiology</source>             <publisher-loc>Wallingford</publisher-loc>             <publisher-name>CAB International</publisher-name>             <fpage>149</fpage>             <lpage>173</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Mann1"><label>50</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Mann</surname><given-names>VH</given-names></name>
<name name-style="western"><surname>Morales</surname><given-names>ME</given-names></name>
<name name-style="western"><surname>Kines</surname><given-names>KJ</given-names></name>
<name name-style="western"><surname>Brindley</surname><given-names>PJ</given-names></name>
</person-group>             <year>2008</year>             <article-title>Transgenesis of schistosomes: approaches employing mobile genetic elements.</article-title>             <source>Parasitology</source>             <volume>135</volume>             <fpage>141</fpage>             <lpage>153</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Boyle1"><label>51</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Boyle</surname><given-names>JP</given-names></name>
<name name-style="western"><surname>Wu</surname><given-names>XJ</given-names></name>
<name name-style="western"><surname>Shoemaker</surname><given-names>CB</given-names></name>
<name name-style="western"><surname>Yoshino</surname><given-names>TP</given-names></name>
</person-group>             <year>2003</year>             <article-title>Using RNA interference to manipulate endogenous gene expression in <italic>Schistosoma mansoni</italic> sporocysts.</article-title>             <source>Mol Biochem Parasitol</source>             <volume>128</volume>             <fpage>205</fpage>             <lpage>215</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Skelly1"><label>52</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Skelly</surname><given-names>PJ</given-names></name>
<name name-style="western"><surname>Da'dara</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Harn</surname><given-names>DA</given-names></name>
</person-group>             <year>2003</year>             <article-title>Suppression of cathepsin B expression in <italic>Schistosoma mansoni</italic> by RNA interference.</article-title>             <source>Int J Parasitol</source>             <volume>33</volume>             <fpage>363</fpage>             <lpage>369</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Correnti1"><label>53</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Correnti</surname><given-names>JM</given-names></name>
<name name-style="western"><surname>Brindley</surname><given-names>PJ</given-names></name>
<name name-style="western"><surname>Pearce</surname><given-names>EJ</given-names></name>
</person-group>             <year>2005</year>             <article-title>Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth.</article-title>             <source>Mol Biochem Parasitol</source>             <volume>143</volume>             <fpage>209</fpage>             <lpage>215</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Delcroix1"><label>54</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Delcroix</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Sajid</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Caffrey</surname><given-names>CR</given-names></name>
<name name-style="western"><surname>Lim</surname><given-names>KC</given-names></name>
<name name-style="western"><surname>Dvořák</surname><given-names>J</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>A multienzyme network functions in intestinal protein digestion by a platyhelminth parasite.</article-title>             <source>J Biol Chem</source>             <volume>281</volume>             <fpage>39316</fpage>             <lpage>39329</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Morales1"><label>55</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Morales</surname><given-names>ME</given-names></name>
<name name-style="western"><surname>Rinaldi</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Gobert</surname><given-names>GN</given-names></name>
<name name-style="western"><surname>Kines</surname><given-names>KJ</given-names></name>
<name name-style="western"><surname>Tort</surname><given-names>JF</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>RNA interference of <italic>Schistosoma mansoni</italic> cathepsin D, the apical enzyme of the hemoglobin proteolysis cascade.</article-title>             <source>Mol Biochem Parasitol</source>             <volume>157</volume>             <fpage>160</fpage>             <lpage>168</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Rinaldi1"><label>56</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Rinaldi</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Morales</surname><given-names>ME</given-names></name>
<name name-style="western"><surname>Alrefaei</surname><given-names>YN</given-names></name>
<name name-style="western"><surname>Cancela</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Castillo</surname><given-names>E</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>RNA interference targeting leucine aminopeptidase blocks hatching of <italic>Schistosoma mansoni</italic> eggs.</article-title>             <source>Mol Biochem Parasitol</source>             <volume>167</volume>             <fpage>118</fpage>             <lpage>126</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Swierczewski1"><label>57</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Swierczewski</surname><given-names>BE</given-names></name>
<name name-style="western"><surname>Davies</surname><given-names>SJ</given-names></name>
</person-group>             <year>2009</year>             <article-title>A schistosome cAMP-dependent protein kinase catalytic subunit is essential for parasite viability.</article-title>             <source>PLoS Negl Trop Dis</source>             <volume>3</volume>             <fpage>e505</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Osman1"><label>58</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Osman</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Niles</surname><given-names>EG</given-names></name>
<name name-style="western"><surname>Verjovski-Almeida</surname><given-names>S</given-names></name>
<name name-style="western"><surname>LoVerde</surname><given-names>PT</given-names></name>
</person-group>             <year>2006</year>             <article-title><italic>Schistosoma mansoni</italic> TGF-beta receptor II: role in host ligand-induced regulation of a schistosome target gene.</article-title>             <source>PLoS Pathog</source>             <volume>2</volume>             <fpage>e54</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Faghiri1"><label>59</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Faghiri</surname><given-names>Z</given-names></name>
<name name-style="western"><surname>Skelly</surname><given-names>PJ</given-names></name>
</person-group>             <year>2009</year>             <article-title>The role of tegumental aquaporin from the human parasitic worm, <italic>Schistosoma mansoni</italic>, in osmoregulation and drug uptake.</article-title>             <source>FASEB J</source>             <volume>23</volume>             <fpage>2780</fpage>             <lpage>2789</lpage>          </element-citation></ref>
<ref id="pntd.0000850-KrautzPeterson1"><label>60</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Krautz-Peterson</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Simoes</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Faghiri</surname><given-names>Z</given-names></name>
<name name-style="western"><surname>Ndegwa</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Oliveira</surname><given-names>G</given-names></name>
<etal/></person-group>             <year>2010</year>             <article-title>Suppressing glucose transporter gene expression in schistosomes impairs parasite feeding and decreases survival in the mammalian host.</article-title>             <source>PLoS Pathog</source>             <volume>6</volume>             <fpage>e1000932</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Tran1"><label>61</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Tran</surname><given-names>MH</given-names></name>
<name name-style="western"><surname>Freitas</surname><given-names>TC</given-names></name>
<name name-style="western"><surname>Cooper</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Gaze</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Gatton</surname><given-names>ML</given-names></name>
<etal/></person-group>             <year>2010</year>             <article-title>Suppression of mRNAs encoding tegument tetraspanins from <italic>Schistosoma mansoni</italic> results in impaired tegument turnover.</article-title>             <source>PLoS Pathog</source>             <volume>6</volume>             <fpage>e1000840</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Kumagai1"><label>62</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kumagai</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Osada</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Ohta</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Kanazawa</surname><given-names>T</given-names></name>
</person-group>             <year>2009</year>             <article-title>Peroxiredoxin-1 from <italic>Schistosoma japonicum</italic> functions as a scavenger against hydrogen peroxide but not nitric oxide.</article-title>             <source>Mol Biochem Parasitol</source>             <volume>164</volume>             <fpage>26</fpage>             <lpage>31</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Kuntz1"><label>63</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kuntz</surname><given-names>AN</given-names></name>
<name name-style="western"><surname>Davioud-Charvet</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Sayed</surname><given-names>AA</given-names></name>
<name name-style="western"><surname>Califf</surname><given-names>LL</given-names></name>
<name name-style="western"><surname>Dessolin</surname><given-names>J</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Thioredoxin glutathione reductase from <italic>Schistosoma mansoni</italic>: an essential parasite enzyme and a key drug target.</article-title>             <source>PLoS Med</source>             <volume>4</volume>             <fpage>e206</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Gomes1"><label>64</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Gomes</surname><given-names>MS</given-names></name>
<name name-style="western"><surname>Cabral</surname><given-names>FJ</given-names></name>
<name name-style="western"><surname>Jannotti-Passos</surname><given-names>LK</given-names></name>
<name name-style="western"><surname>Carvalho</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Rodrigues</surname><given-names>V</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Preliminary analysis of miRNA pathway in <italic>Schistosoma mansoni</italic>.</article-title>             <source>Parasitol Int</source>             <volume>58</volume>             <fpage>61</fpage>             <lpage>68</lpage>          </element-citation></ref>
<ref id="pntd.0000850-KrautzPeterson2"><label>65</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Krautz-Peterson</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Bhardwaj</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Faghiri</surname><given-names>Z</given-names></name>
<name name-style="western"><surname>Tararam</surname><given-names>CA</given-names></name>
<name name-style="western"><surname>Skelly</surname><given-names>PJ</given-names></name>
</person-group>             <year>2009</year>             <article-title>RNA interference in schistosomes: machinery and methodology.</article-title>             <source>Parasitology</source>             <fpage>1</fpage>             <lpage>11</lpage>          </element-citation></ref>
<ref id="pntd.0000850-KrautzPeterson3"><label>66</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Krautz-Peterson</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Skelly</surname><given-names>PJ</given-names></name>
</person-group>             <year>2008</year>             <article-title><italic>Schistosoma mansoni</italic>: the dicer gene and its expression.</article-title>             <source>Exp Parasitol</source>             <volume>118</volume>             <fpage>122</fpage>             <lpage>128</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Hannon1"><label>67</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hannon</surname><given-names>GJ</given-names></name>
<name name-style="western"><surname>Rossi</surname><given-names>JJ</given-names></name>
</person-group>             <year>2004</year>             <article-title>Unlocking the potential of the human genome with RNA interference.</article-title>             <source>Nature</source>             <volume>431</volume>             <fpage>371</fpage>             <lpage>378</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Jackson1"><label>68</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Jackson</surname><given-names>AL</given-names></name>
<name name-style="western"><surname>Bartz</surname><given-names>SR</given-names></name>
<name name-style="western"><surname>Schelter</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Kobayashi</surname><given-names>SV</given-names></name>
<name name-style="western"><surname>Burchard</surname><given-names>J</given-names></name>
<etal/></person-group>             <year>2003</year>             <article-title>Expression profiling reveals off-target gene regulation by RNAi.</article-title>             <source>Nat Biotechnol</source>             <volume>21</volume>             <fpage>635</fpage>             <lpage>637</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Kulkarni1"><label>69</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kulkarni</surname><given-names>MM</given-names></name>
<name name-style="western"><surname>Booker</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Silver</surname><given-names>SJ</given-names></name>
<name name-style="western"><surname>Friedman</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Hong</surname><given-names>P</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Evidence of off-target effects associated with long dsRNAs in Drosophila melanogaster cell-based assays.</article-title>             <source>Nat Methods</source>             <volume>3</volume>             <fpage>833</fpage>             <lpage>838</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Ma1"><label>70</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Creanga</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Lum</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Beachy</surname><given-names>PA</given-names></name>
</person-group>             <year>2006</year>             <article-title>Prevalence of off-target effects in Drosophila RNA interference screens.</article-title>             <source>Nature</source>             <volume>443</volume>             <fpage>359</fpage>             <lpage>363</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Sarov1"><label>71</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Sarov</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Stewart</surname><given-names>AF</given-names></name>
</person-group>             <year>2005</year>             <article-title>The best control for the specificity of RNAi.</article-title>             <source>Trends Biotechnol</source>             <volume>23</volume>             <fpage>446</fpage>             <lpage>448</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Sudbery1"><label>72</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Sudbery</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Enright</surname><given-names>AJ</given-names></name>
<name name-style="western"><surname>Fraser</surname><given-names>AG</given-names></name>
<name name-style="western"><surname>Dunham</surname><given-names>I</given-names></name>
</person-group>             <year>2010</year>             <article-title>Systematic analysis of off-target effects in an RNAi screen reveals microRNAs affecting sensitivity to TRAIL-induced apoptosis.</article-title>             <source>BMC Genomics</source>             <volume>11</volume>             <fpage>175</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Fedorov1"><label>73</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Fedorov</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Anderson</surname><given-names>EM</given-names></name>
<name name-style="western"><surname>Birmingham</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Reynolds</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Karpilow</surname><given-names>J</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Off-target effects by siRNA can induce toxic phenotype.</article-title>             <source>RNA</source>             <volume>12</volume>             <fpage>1188</fpage>             <lpage>1196</lpage>          </element-citation></ref>
<ref id="pntd.0000850-deMoraesMouro1"><label>74</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>de Moraes Mourão</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Dinguirard</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Franco</surname><given-names>GR</given-names></name>
<name name-style="western"><surname>Yoshino</surname><given-names>TP</given-names></name>
</person-group>             <year>2009</year>             <article-title>Phenotypic screen of early-developing larvae of the blood fluke, Schistosoma mansoni, using RNA interference.</article-title>             <source>PLoS Negl Trop Dis</source>             <volume>3</volume>             <fpage>e502</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Mouro1"><label>75</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Mourão</surname><given-names>MM</given-names></name>
<name name-style="western"><surname>Dinguirard</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Franco</surname><given-names>GR</given-names></name>
<name name-style="western"><surname>Yoshino</surname><given-names>TP</given-names></name>
</person-group>             <year>2009</year>             <article-title>Correction: phenotypic screen of early-developing larvae of the blood fluke, <italic>Schistosoma mansoni</italic>, using RNA interference.</article-title>             <source>PLoS Negl Trop Dis</source>             <volume>3</volume>          </element-citation></ref>
<ref id="pntd.0000850-Abdulla2"><label>76</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Abdulla</surname><given-names>MH</given-names></name>
<name name-style="western"><surname>Ruelas</surname><given-names>DS</given-names></name>
<name name-style="western"><surname>Wolff</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Snedecor</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Lim</surname><given-names>KC</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening.</article-title>             <source>PLoS Negl Trop Dis</source>             <volume>3</volume>             <fpage>e478</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Colley1"><label>77</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Colley</surname><given-names>DG</given-names></name>
<name name-style="western"><surname>Wikel</surname><given-names>SK</given-names></name>
</person-group>             <year>1974</year>             <article-title><italic>Schistosoma mansoni</italic>: simplified method for the production of schistosomules.</article-title>             <source>Exp Parasitol</source>             <volume>35</volume>             <fpage>44</fpage>             <lpage>51</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Basch1"><label>78</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Basch</surname><given-names>PF</given-names></name>
</person-group>             <year>1981</year>             <article-title>Cultivation of <italic>Schistosoma mansoni in vitro</italic>. I. Establishment of cultures from cercariae and development until pairing.</article-title>             <source>J Parasitol</source>             <volume>67</volume>             <fpage>179</fpage>             <lpage>185</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Caffrey3"><label>79</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Caffrey</surname><given-names>CR</given-names></name>
<name name-style="western"><surname>McKerrow</surname><given-names>JH</given-names></name>
<name name-style="western"><surname>Salter</surname><given-names>JP</given-names></name>
<name name-style="western"><surname>Sajid</surname><given-names>M</given-names></name>
</person-group>             <year>2004</year>             <article-title>Blood ‘n’ guts: an update on schistosome digestive peptidases.</article-title>             <source>Trends Parasitol</source>             <volume>20</volume>             <fpage>241</fpage>             <lpage>248</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Braschi1"><label>80</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Braschi</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Wilson</surname><given-names>RA</given-names></name>
</person-group>             <year>2006</year>             <article-title>Proteins exposed at the adult schistosome surface revealed by biotinylation.</article-title>             <source>Mol Cell Proteomics</source>             <volume>5</volume>             <fpage>347</fpage>             <lpage>356</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Tararam1"><label>81</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Tararam</surname><given-names>CA</given-names></name>
<name name-style="western"><surname>Farias</surname><given-names>LP</given-names></name>
<name name-style="western"><surname>Wilson</surname><given-names>RA</given-names></name>
<name name-style="western"><surname>Leite</surname><given-names>LC</given-names></name>
</person-group>             <year>2010</year>             <article-title><italic>Schistosoma mansoni</italic> Annexin 2: Molecular characterization and immunolocalization.</article-title>             <source>Exp Parasitol</source>             <volume>126</volume>             <fpage>146</fpage>             <lpage>155</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Caffrey4"><label>82</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Caffrey</surname><given-names>CR</given-names></name>
<name name-style="western"><surname>Salter</surname><given-names>JP</given-names></name>
<name name-style="western"><surname>Lucas</surname><given-names>KD</given-names></name>
<name name-style="western"><surname>Khiem</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Hsieh</surname><given-names>I</given-names></name>
<etal/></person-group>             <year>2002</year>             <article-title>SmCB2, a novel tegumental cathepsin B from adult <italic>Schistosoma mansoni</italic>.</article-title>             <source>Mol Biochem Parasitol</source>             <volume>121</volume>             <fpage>49</fpage>             <lpage>61</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Rescher1"><label>83</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Rescher</surname><given-names>U</given-names></name>
<name name-style="western"><surname>Gerke</surname><given-names>V</given-names></name>
</person-group>             <year>2004</year>             <article-title>Annexins-unique membrane binding proteins with diverse functions.</article-title>             <source>J Cell Sci</source>             <volume>117</volume>             <fpage>2631</fpage>             <lpage>2639</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Shaner1"><label>84</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Shaner</surname><given-names>NC</given-names></name>
<name name-style="western"><surname>Campbell</surname><given-names>RE</given-names></name>
<name name-style="western"><surname>Steinbach</surname><given-names>PA</given-names></name>
<name name-style="western"><surname>Giepmans</surname><given-names>BN</given-names></name>
<name name-style="western"><surname>Palmer</surname><given-names>AE</given-names></name>
<etal/></person-group>             <year>2004</year>             <article-title>Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein.</article-title>             <source>Nat Biotechnol</source>             <volume>22</volume>             <fpage>1567</fpage>             <lpage>1572</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Rozen1"><label>85</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Rozen</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Skaletsky</surname><given-names>H</given-names></name>
</person-group>             <year>2000</year>             <article-title>Primer3 on the WWW for general users and for biologist programmers.</article-title>             <source>Methods Mol Biol</source>             <volume>132</volume>             <fpage>365</fpage>             <lpage>386</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Nolan1"><label>86</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Nolan</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Hands</surname><given-names>RE</given-names></name>
<name name-style="western"><surname>Bustin</surname><given-names>SA</given-names></name>
</person-group>             <year>2006</year>             <article-title>Quantification of mRNA using real-time RT-PCR.</article-title>             <source>Nat Protoc</source>             <volume>1</volume>             <fpage>1559</fpage>             <lpage>1582</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Bookout1"><label>87</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Bookout</surname><given-names>AL</given-names></name>
<name name-style="western"><surname>Mangelsdorf</surname><given-names>DJ</given-names></name>
</person-group>             <year>2003</year>             <article-title>Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways.</article-title>             <source>Nucl Recept Signal</source>             <volume>1</volume>             <fpage>e012</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Le1"><label>88</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Le</surname><given-names>TH</given-names></name>
<name name-style="western"><surname>Blair</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Agatsuma</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Humair</surname><given-names>PF</given-names></name>
<name name-style="western"><surname>Campbell</surname><given-names>NJ</given-names></name>
<etal/></person-group>             <year>2000</year>             <article-title>Phylogenies inferred from mitochondrial gene orders-a cautionary tale from the parasitic flatworms.</article-title>             <source>Mol Biol Evol</source>             <volume>17</volume>             <fpage>1123</fpage>             <lpage>1125</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Dvok2"><label>89</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Dvořák</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Mashiyama</surname><given-names>ST</given-names></name>
<name name-style="western"><surname>Sajid</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Braschi</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Delcroix</surname><given-names>M</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>SmCL3, a gastrodermal cysteine protease of the human blood fluke <italic>Schistosoma mansoni</italic>.</article-title>             <source>PLoS Negl Trop Dis</source>             <volume>3</volume>             <fpage>e449</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Livak1"><label>90</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Livak</surname><given-names>KJ</given-names></name>
<name name-style="western"><surname>Schmittgen</surname><given-names>TD</given-names></name>
</person-group>             <year>2001</year>             <article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method.</article-title>             <source>Methods</source>             <volume>25</volume>             <fpage>402</fpage>             <lpage>408</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Yuan1"><label>91</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Yuan</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Verhelst</surname><given-names>SH</given-names></name>
<name name-style="western"><surname>Blum</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Coussens</surname><given-names>LM</given-names></name>
<name name-style="western"><surname>Bogyo</surname><given-names>M</given-names></name>
</person-group>             <year>2006</year>             <article-title>A selective activity-based probe for the papain family cysteine protease dipeptidyl peptidase I/cathepsin C.</article-title>             <source>J Am Chem Soc</source>             <volume>128</volume>             <fpage>5616</fpage>             <lpage>5617</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Murata1"><label>92</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Murata</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Miyashita</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Yokoo</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Tamai</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Hanada</surname><given-names>K</given-names></name>
<etal/></person-group>             <year>1991</year>             <article-title>Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, <italic>in vitro</italic>.</article-title>             <source>FEBS Lett</source>             <volume>280</volume>             <fpage>307</fpage>             <lpage>310</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Sojka1"><label>93</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Sojka</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Franta</surname><given-names>Z</given-names></name>
<name name-style="western"><surname>Horn</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Hajdusek</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Caffrey</surname><given-names>CR</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>Profiling of proteolytic enzymes in the gut of the tick <italic>Ixodes ricinus</italic> reveals an evolutionarily conserved network of aspartic and cysteine peptidases.</article-title>             <source>Parasit Vectors</source>             <volume>1</volume>             <fpage>7</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Brmme1"><label>94</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Brömme</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Klaus</surname><given-names>JL</given-names></name>
<name name-style="western"><surname>Okamoto</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Rasnick</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Palmer</surname><given-names>JT</given-names></name>
</person-group>             <year>1996</year>             <article-title>Peptidyl vinyl sulphones: a new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L.</article-title>             <source>Biochem J</source>             <volume>315 ( Pt 1)</volume>             <fpage>85</fpage>             <lpage>89</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Kirschke1"><label>95</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kirschke</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Shaw</surname><given-names>E</given-names></name>
</person-group>             <year>1981</year>             <article-title>Rapid interaction of cathepsin L by Z-Phe-PheCHN12 and Z-Phe-AlaCHN2.</article-title>             <source>Biochem Biophys Res Commun</source>             <volume>101</volume>             <fpage>454</fpage>             <lpage>458</lpage>          </element-citation></ref>
<ref id="pntd.0000850-KrautzPeterson4"><label>96</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Krautz-Peterson</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Radwanska</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Ndegwa</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Shoemaker</surname><given-names>CB</given-names></name>
<name name-style="western"><surname>Skelly</surname><given-names>PJ</given-names></name>
</person-group>             <year>2007</year>             <article-title>Optimizing gene suppression in schistosomes using RNA interference.</article-title>             <source>Mol Biochem Parasitol</source>             <volume>153</volume>             <fpage>194</fpage>             <lpage>202</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Morales2"><label>97</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Morales</surname><given-names>FC</given-names></name>
<name name-style="western"><surname>Furtado</surname><given-names>DR</given-names></name>
<name name-style="western"><surname>Rumjanek</surname><given-names>FD</given-names></name>
</person-group>             <year>2004</year>             <article-title>The N-terminus moiety of the cystatin SmCys from <italic>Schistosoma mansoni</italic> regulates its inhibitory activity <italic>in vitro</italic> and <italic>in vivo</italic>.</article-title>             <source>Mol Biochem Parasitol</source>             <volume>134</volume>             <fpage>65</fpage>             <lpage>73</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Ndegwa1"><label>98</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ndegwa</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Krautz-Peterson</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Skelly</surname><given-names>PJ</given-names></name>
</person-group>             <year>2007</year>             <article-title>Protocols for gene silencing in schistosomes.</article-title>             <source>Exp Parasitol</source>             <volume>117</volume>             <fpage>284</fpage>             <lpage>291</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Kiefer1"><label>99</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kiefer</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Yin</surname><given-names>HH</given-names></name>
<name name-style="western"><surname>Que</surname><given-names>QQ</given-names></name>
<name name-style="western"><surname>Mousses</surname><given-names>S</given-names></name>
</person-group>             <year>2009</year>             <article-title>High-throughput siRNA screening as a method of perturbation of biological systems and identification of targeted pathways coupled with compound screening.</article-title>             <source>Methods Mol Biol</source>             <volume>563</volume>             <fpage>275</fpage>             <lpage>287</lpage>          </element-citation></ref>
<ref id="pntd.0000850-MacKeigan1"><label>100</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>MacKeigan</surname><given-names>JP</given-names></name>
<name name-style="western"><surname>Murphy</surname><given-names>LO</given-names></name>
<name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name>
</person-group>             <year>2005</year>             <article-title>Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance.</article-title>             <source>Nat Cell Biol</source>             <volume>7</volume>             <fpage>591</fpage>             <lpage>600</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Perrimon1"><label>101</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Perrimon</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Friedman</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Mathey-Prevot</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Eggert</surname><given-names>US</given-names></name>
</person-group>             <year>2007</year>             <article-title>Drug-target identification in Drosophila cells: combining high-throughout RNAi and small-molecule screens.</article-title>             <source>Drug Discov Today</source>             <volume>12</volume>             <fpage>28</fpage>             <lpage>33</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Cherry1"><label>102</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Cherry</surname><given-names>S</given-names></name>
</person-group>             <year>2008</year>             <article-title>Genomic RNAi screening in Drosophila S2 cells: what have we learned about host-pathogen interactions?</article-title>             <source>Curr Opin Microbiol</source>             <volume>11</volume>             <fpage>262</fpage>             <lpage>270</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Prudencio1"><label>103</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Prudencio</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Rodrigues</surname><given-names>CD</given-names></name>
<name name-style="western"><surname>Hannus</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Martin</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Real</surname><given-names>E</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>Kinome-wide RNAi screen implicates at least 5 host hepatocyte kinases in Plasmodium sporozoite infection.</article-title>             <source>PLoS Pathog</source>             <volume>4</volume>             <fpage>e1000201</fpage>          </element-citation></ref>
<ref id="pntd.0000850-Cheever1"><label>104</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Cheever</surname><given-names>AW</given-names></name>
<name name-style="western"><surname>Weller</surname><given-names>TH</given-names></name>
</person-group>             <year>1958</year>             <article-title>Observations on the growth and nutritional requirements of <italic>Schistosoma mansoni in vitro</italic>.</article-title>             <source>Am J Hyg</source>             <volume>68</volume>             <fpage>322</fpage>             <lpage>339</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Clegg1"><label>105</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Clegg</surname><given-names>JA</given-names></name>
</person-group>             <year>1965</year>             <article-title><italic>In vitro</italic> cultivation of <italic>Schistosoma mansoni</italic>.</article-title>             <source>Exp Parasitol</source>             <volume>16</volume>             <fpage>133</fpage>             <lpage>147</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Cousin1"><label>106</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Cousin</surname><given-names>CE</given-names></name>
<name name-style="western"><surname>Stirewalt</surname><given-names>MA</given-names></name>
<name name-style="western"><surname>Dorsey</surname><given-names>CH</given-names></name>
<name name-style="western"><surname>Watson</surname><given-names>LP</given-names></name>
</person-group>             <year>1986</year>             <article-title><italic>Schistosoma mansoni</italic>: comparative development of schistosomules produced by artificial techniques.</article-title>             <source>J Parasitol</source>             <volume>72</volume>             <fpage>606</fpage>             <lpage>609</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Jensen1"><label>107</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Jensen</surname><given-names>DV</given-names></name>
<name name-style="western"><surname>Stirewalt</surname><given-names>MA</given-names></name>
<name name-style="western"><surname>Walters</surname><given-names>M</given-names></name>
</person-group>             <year>1965</year>             <article-title>Growth of <italic>Schistosoma mansoni</italic> cercariae under dialysis membranes in Rose multipurpose chambers.</article-title>             <source>Exp Parasitol</source>             <volume>17</volume>             <fpage>15</fpage>             <lpage>23</lpage>          </element-citation></ref>
<ref id="pntd.0000850-Thornhill1"><label>108</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Thornhill</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Coelho</surname><given-names>PM</given-names></name>
<name name-style="western"><surname>McVeigh</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Maule</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Jurberg</surname><given-names>AD</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title><italic>Schistosoma mansoni</italic> cercariae experience influx of macromolecules during skin penetration.</article-title>             <source>Parasitology</source>             <volume>136</volume>             <fpage>1257</fpage>             <lpage>1267</lpage>          </element-citation></ref>
</ref-list>

</back>
</article>